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Abstract 
 
Hot flashes are a significant problem for many women with naturally occurring 
menopause and can cause physical symptoms as well as a decreased quality of life. In the 
past women were treated with hormonal replacement therapy. However, recent research 
has shown that the risks may outweigh the benefits. In addition, nontraditional nutritional 
treatments, such as herbal supplements, are not approved by the Food and Drug 
Administration, and often, the exact amount of the substance contained in each dose 
cannot be guaranteed. Many women and their doctors are looking for an alternative 
treatment. The use of hypnosis has been shown to be an effective treatment tool with 
many medical disorders. Through three case studies, this study examines the use of 
hypnosis as an effective treatment for the hot flashes caused by naturally occurring 
menopause as a means to reduce or to eliminate the intensity and frequency of hot 
flashes. It also explores the perceptions that women have about menopause and looks at 
what their menopausal experience has been.  
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Statement of the Problem 
 
Menopause marks the phase in a woman‟s life when reproductive hormonal 
secretion decreases, reproductive ability stops and menstruation ends. In 1998, the North 
American Menopause Society (NAMS) conducted a survey and found that the average 
age of a woman‟s last menstrual period was 49 (Utian & Boggs, 1999). During this time, 
the ovaries gradually produce lower levels of sex hormones--estrogen and progesterone. 
Estrogen promotes the development of a woman‟s breasts and uterus, controls the cycle 
of ovulation (when an ovary releases an egg into a fallopian tube), and affects many 
aspects of a woman‟s physical and emotional health. Progesterone controls menstruation 
and prepares the lining of the uterus to receive the fertilized egg. “Natural menopause”, 
which begins when a woman has her last period, or when she stops menstruating, is 
considered complete when menstruation has stopped for 1 year. Although there has been 
an increase in life expectancy over the years, the age of menopause has not changed 
during the past few centuries, unaffected by improving nutrition and reduction of disease. 
In previous centuries, fewer women lived beyond menopause because life spans were 
shorter; today, most women are postmenopausal for at least one-third of their lives. In the 
United States in 2000, there were an estimated 42 million women over the age 50. About 
33 million women are over 55 years of age (compared with about 28 million in 1990). By 
the year 2020, the number of US women over 55 is expected to be about 46 million. A
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 woman‟s life expectancy is estimated at 79.7 years. Today, a woman who reaches 54 can 
expect to reach the age of 84.3 years. About two-thirds of the total US population will 
survive to age 85 or older (About Menopause, 2005). 
Some women experience very little discomfort during menopause but others have 
symptoms that affect their quality of life and day to day functioning. The symptoms of 
menopause include hot flashes, night sweats, mood swings, and changes in the vagina, 
such as dryness or pain during intercourse. Seventy-five percent to 85% of women report 
hot flashes (Johnson, 1999). A hot flash is described by Kronenberg (1994) as a 
“transient episode of flushing, sweating, and a sensation of heat, often accompanied by 
palpitations and a feeling of anxiety, and sometimes followed by chills.”  When these hot 
flashes occur during a woman‟s sleep she is often, on waking, soaking wet (night sweats). 
Pansini et al. (1994) also described the many physical symptoms associated with hot 
flashes. The most common symptoms include headaches, irritability, palpitations, 
paresthesias (a sensation of pricking, tingling, or creeping on the skin), and dizziness. 
Other symptoms are often associated with hot flashes, such as sleep disturbance, fatigue, 
mood change, and anxiety. Hot flashes can lead to a disruption of daily life because of 
related physical discomfort, social embarrassment, and feelings of annoyance and 
helplessness. Hunter and Liao (1995) found that one-third of women with hot flashes 
described embarrassment, and 20% described a general sense of loss of control. 
Menopause is a significant public health issue because of three factors: (1) 
menopause affects every woman; (2) an unprecedented number of women are reaching 
midlife, and (3) more women are living beyond age 65, with the elderly population also 
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reaching unprecedented numbers. Therefore, treating this population gives clinicians an 
excellent opportunity to make a significant impact on public health.  
The traditional medical treatment for menopause symptoms involves hormone 
replacement therapy (HRT), a treatment that is used to supply the body either with 
estrogen alone or estrogen with progesterone combination. Estrogen and progesterone are 
hormones that are naturally produced by a woman‟s ovaries. When the ovaries no longer 
produce adequate amounts of these hormones (as in menopause) hormone therapy can be 
given to supply the body with adequate levels of estrogen and progesterone (webMD 
Health, 2004).  
HRT was the treatment of choice given by doctors for many years. HRT reduces 
the number and intensity of hot flashes experienced by women and therefore reduces the 
anxiety and feelings of loss of control. Data from a 1997 national survey showed that 45 
percent of U.S. women born between 1897 and 1950 used menopausal hormones for at 
least 1 month, and 20 percent continued its use for 5 or more years (National Cancer 
Institute, 2003). Recently, HTR has become very controversial and doctors are reluctant 
to prescribe it for their patients.  
 Because of the concerns about medical treatments using hormones, other, more 
“natural” treatments such as dietary and herbal supplements, acupuncture, chiropractic, 
and massage therapy, homeopathy and botanicals have been used for menopause 
symptoms, but scientific evidence for the effectiveness of most of these alternative 
treatment methods is lacking.  
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Purpose of the Study 
 
 Studies such as the “Women‟s Health Initiative” and “Million Women Study” 
have made many women and their doctors increasingly reluctant to use synthetic 
hormones and they are searching for more natural and less artificial substances or 
treatments that will provide relief from the symptoms, yet not cause any additional 
problems. The nontraditional or “natural” treatments have had little or no research 
showing that they are effective and until they are investigated further it is not known if 
they, too, have unwanted side effects. In addition, nontraditional nutritional treatments 
such as herbal supplements are not approved by the Food and Drug Administration, and 
often the exact amount of the substance contained in each dose of such supplements 
cannot be guaranteed. Finding an alternative treatment for menopause symptoms that 
effectively deals with the physical problems (i.e., hot flashes) and the psychological 
aspects (i.e., anxiety, feelings of loss of control) without side effects would benefit many 
women.  
 The purpose of this study was to see whether or not hypnosis would be an 
effective treatment for menopause symptoms, specifically hot flashes. Hypnosis has been 
used for many years for medical disorders as an adjunct and/or alternative to more 
traditional treatments. 
A review of hypnosis in contemporary medicine (Stewart, 2005) examined the 
uses of hypnosis in many areas of medicine including anesthesia for pain relief and 
surgery, healing from surgery or injury, dermatology, gastroenterology, hematology, 
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neurology, obstetrics, oncology, otorhinolaryngology, smoking cessation, rheumatology, 
and urology.  
Only one study was found that used hypnosis to control menopausal symptoms. 
This study investigated whether or not hypnosis would be beneficial for breast cancer 
survivors in causing the reduction of hot flashes (Elkin, Marcus, Palamara & Stearns, 
2004). The treatment for breast cancer often puts women into an early menopause. In two 
case studies hypnosis was found to be effective 77% and 76% of the time.  
There are several benefits to using hypnosis as a treatment for menopause. First, 
when hypnosis is practiced by a competent clinician there are no side effects. Another 
benefit is that hypnosis is a way of enhancing people‟s control over their body‟s 
functioning. This is especially important because, as previously noted, 20% of women 
described a general sense of loss of control when faced with hot flashes (Hunter & Laos, 
1995). 
The use of hypnosis has been shown to be an effective treatment tool with many 
medical disorders, including the hot flashes experienced by breast cancer survivors. 
Hypnosis may prove to be a promising treatment for hot flashes in naturally occurring 
menopause as well. With a growing concern about HRT and limited or no research 
showing that nontraditional or natural treatments are effective for hot flashes, the 
treatment options for women are few. Hypnosis is an intervention that might prove 
fruitful to treat the symptoms of menopause and should be investigated further.   





Menopause does not occur as an isolated event and therefore it should be 
understood and investigated as part of a developmental phase in a woman‟s life. 
Hormonal alterations are not the only changes taking place during this period, because 
the midlife years can also be associated with many important transitions for women. 
These include changes in social roles, dealing not only with the phases of adolescence 
seen in one‟s children, but also with their departure from the childhood home, the illness 
of partners, and the illness or death of elderly parents. (Unger & Crawford, 1996; Ballard, 
Kuh, & Wadsworth, 2001; Palacios, Tobar, & Menendez, 2002; Short, 2003). It is 
important that menopause be placed within the context of a woman‟s daily life because it 
greatly influences a woman‟s attitude toward herself and her aging. Any study of 
menopause should include a consideration of a woman‟s psychological state and 
influences, her sexual orientation, her cultural and social background, her social contexts, 
the microenvironment of the household, and the aging process (Woods & Mitchell, 1997; 
Carolan, 2000; Hewner, 2001; Deeks, 2003; Woods & Mitchell, 2005).  
The significance of bodily changes during the menopausal transition should also 
not be neglected, because physical appearance is of great importance for social judgments 
about women (Unger & Crawford, 1996). Because of the cumulative effect of these 
biological, psychological, and social changes, menopause may be a stressful and 
challenging period for women, or it could also be a time of liberation and freedom and a 
turning point during which important decisions are made about one‟s life. Menopause can 
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offer an opportunity for reflection and personal growth (Ballard, Kuh, & Wadsworth, 
2001; Choi, 1995) and the challenges experienced during this period may, in fact, serve 
as precursors of psychological growth.  
 
Menopause 
According to estimates from the North American Menopause Society, nearly 40 
million women in the United States experienced natural menopause as of the year 2000 
(North American Menopause Society, 2000). Natural menopause is defined as a 
spontaneous, permanent ending of menstruation in which the menses have ceased for at 
least 12 uninterrupted months. A transitional period occurs prior to menopause called the 
climacteric or perimenopause; actual menopause occurs in the United States between 
ages 40 and 58. In 1800, only five percent of women in the United States lived past age 
50. A century later, with advances in public sanitation and better nutrition, women‟s 
average life expectancy rose to 49 years. A baby girl born today can look forward to an 
average life expectancy of 84.3 years (About Menopause, 2005). The average age of the 
population is expected to continue to rise; this is due to the aging of the baby boomers 
and their decreasing death rates, and it will not reach a peak until around 2031 (Evans, 
2000). 
Symptoms of menopause range from mild to severe, with the classic symptom 
being the hot flash. The prevalence of symptoms is subject to wide cultural differences, 
but is appreciably higher in Western women. For example, women in the United States 
report more hot flashes (Johnson, 1998; Speroff , Glass, & Kase, 1999) than women from 
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developing countries, where menopause generally seems to be associated with fewer 
complaints(Beyene, 1986; Lock, 1991). 
 
Biological Changes That Occur in Menopause 
For a an understanding of the biology of menopause the following is an excerpt 
from A Woman‟s Guide to Menopause & Perimenopause, by Mary Minkin, MD, and 
Carol Wright, PhD (2004). Menopause is not something that happens but something that 
stops happening, not an event but a nonevent. By definition, menopause is the cessation 
of menses caused by the cessation of ovarian function, in other words, the end of the 
menstrual cycles caused by the shutdown of the ovaries. It represents the end of about 
forty years of monthly menstrual cycles. After producing, nurturing, and sending out an 
egg cell every month-except during pregnancies-the ovaries finally wear out and cease 
functioning. Menopause has one well-defined endpoint, the final menstrual period. The 
changes leading up to this event, however, may make themselves evident for as long as 
ten years. “Perimenopause,” which means “around menopause,” describes these years, as 
the time when a woman starts to notice menopausal symptoms: hot flashes, sleep 
disruptions, mood swings and other signs, many of them annoying. In order to understand 
the changes that lead up to menopause, it is helpful to understand something about the 
years that preceded it as well as an understanding of basic female physiology.  
The main players in the process of menopause are the ovaries. The ovaries have 
two functions: to make eggs and to make sex hormones, mainly estrogen and 
progesterone, but also a few others. The ovaries make estrogen in several forms, the most 
important of which is estradiol. Other forms are estriol and estrone, but all three are 
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usually grouped under the single name “estrogen.” This hormone is important in 
changing a girl into a woman, in contributing to the growth spurt of adolescence, in the 
maturation of the uterus and other reproduction organs, and in the development of female 
sex characteristics. Estrogen also plays a major part in regulating the menstrual cycle, 
influencing other organs that are seemingly unrelated to reproduction. The second 
important ovarian hormone is progesterone, which along with estrogen regulates the 
menstrual cycle. 
In addition to estrogen and progesterone, generally known as the female sex 
hormones, the ovaries produce small amounts of male sex hormones called androgens, 
including testosterone. In women, testosterone seems to have a role in the female sex 
drive and in assertiveness, and it may account for certain “masculine” traits (such as 
facial hair) in postmenopausal women.  
The other important function of the ovaries is to produce eggs. The ovaries are 
formed during fetal life, as are the egg cells within them. Early in fetal life, the future 
baby girl carries within her immature ovaries about a million eggs, her full complement 
for a lifetime; at birth, this number has dwindled to perhaps four hundred thousand. Only 
a small fraction of these, perhaps four hundred, are destined to reach maturity; the others 
degenerate at some point in their development and at menopause only a few remain. This 
state of events means that a woman‟s egg cells are the same age as she, a fact that is 
important to older women who are seeking to bear children. Consequently, the eggs that 
are available to be fertilized when a woman is forty-five are twenty-five years older than 
the eggs that were available for fertilization when she was twenty. Statistics have 
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confirmed that certain birth defects, in particular Down syndrome, result from 
chromosomal changes that take place in the eggs as they age. 
By the time a girl reaches puberty, more than half of the million eggs that were 
formed prenatally have been lost. The others are at rest, encapsulated in structures that 
will form the ovarian follicles. In their simplest or primordial state, the follicles consist of 
the egg cell surrounded by a single layer of cells called granulosa cells. When the ovaries 
become more active at puberty, the eggs begin to develop. Every month some of the 
follicles start growing. In each growing follicle the granulosa cells divide and reproduce 
many times so that soon, instead of a single layer, layers and layers of them surround the 
egg cell; these granulosa cells make most of the estrogen in the body. The cells in the 
ovary around the outside of the follicle contribute to the process, too, causing the outer 
layer of the follicle to grow and its cells, in turn, to differentiate. When the follicle 
reaches a certain size, it then develops a fluid-filled pocket, which gets bigger and bigger 
as the cycle continues. 
About a week into the menstrual cycle, a selected process takes place. The biggest 
follicle of the group that is growing and differentiating is chosen to be “follicle of the 
month”-in science terminology, the dominant follicle. It continues to increase in size but 
the other follicles degenerate and die off. (Once in a while the signals get crossed and 
more than one follicle continues to develop, creating the possibility of fraternal twins.) 
When the dominant follicle reaches a certain size, it ruptures. The egg cell and 
some of the surrounding granulosa cells burst through the wall of the ovary, an event that 
is known as ovulation. This happens on about day fourteen of the twenty-eight-day 
menstrual cycle. If all goes well, the egg cell is swept into the fallopian tube. The ends of 
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the tube have specialized cells whose hair- like projections sweep back and forth, beating 
in waves and propelling the egg cell toward the interior of the tube. Once in the tube, the 
egg may or may not be fertilized. This part of the cycle, which deals with the 
development of the follicles, is called the follicular phase. 
Meanwhile, in the ovary, what is left of the follicle starts to become active again. 
It changes into a glandlike structure called the corpus luteum, the Latin word for “yellow 
body,” which indeed is the color of the follicle remnant. If the egg cell in the fallopian 
tube does not meet any sperm and get fertilized, the corpus luteum reaches its maximum 
growth in about ten days (day twenty-four of the cycle) and in its turn begins to 
degenerate. But during its short life span (in a nonpregnant woman), the corpus luteum is 
very active and secretes large amounts both of progesterone and of estrogen. 
All of this action in the ovaries brings about changes in the uterine lining, or 
endometrium. As the follicles within the ovaries enlarge and develop, the lining of the 
uterus begins to thicken and proliferate in response to the estrogen produced in the 
ovaries. After ovulation takes place, roughly on day fourteen, the estrogen level again 
rises. The additional progesterone produced by the corpus luteum acts on the endometrial 
tissue to stabilize it and turn it into a hospitable environment, ready to receive an egg 
should fertilization occur. 
If fertilization does not occur and the once active corpus luteum degenerates (on 
about day twenty-eight of the cycle), there is a sudden shutdown in the production both of 
progesterone and of estrogen and the endometrium is deprived of its support system. The 
uterine blood vessels constrict, so that the lining has a diminished supply of oxygen and 
of nutrients. The muscular tissue of the uterus begins to contract rhythmically. Soon the 
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uterine lining disintegrates and is sloughed off as menstrual blood, except for a thin deep 
layer that will start regenerating the endometrium for the next cycle. This part of the 
menstrual cycle, from ovulation on day fourteen to the onset of menstruation on day 
twenty-eight, is called the luteal phase. 
This routine is complex and carefully organized. The organizers or controllers, the 
agents that start and stop the different actions of the cycle, are hormones and, in fact, the 
very name “hormone” comes from a Greek verb meaning “to surge on” or “rouse.” 
Although the ovaries are the chief producers of the female sex hormones estrogen and 
progesterone, they do not do their job in isolation but are part of a chain of command that 
begins (to the best of anyone‟s knowledge) in the brain. The remotest roots of the 
sequence seem to be in the cerebral cortex, the mass of gray matter that is known to play 
a role in memory, language acquisition, and motor control. The exact action of the 
cerebral cortex in the hormonal regulation of the menstrual cycle is not yet known, but 
the cortex seems to influence such changes as the loss of periods during times of stress. 
The next player in the sequence is the hypothalamus, a small region of the brain 
that lies above the pituitary gland (and below an area called the thalamus, as the name 
suggests). Although tiny, the hypothalamus has a role in regulating the internal 
environment of the body, for example, influencing the water balance within the cells and 
tissues, eating behavior, and the daily sleep and walking cycle. The hypothalamus also 
increases the hormones that will trigger menstruation. Starting around the time of 
puberty, the hypothalamus initiates the ovarian cycle every month by secreting a 
hormone called GnRH, gonadotropin-releasing hormone. The gonadotropins, which are 
lutenizing hormone (LH) and follicle stimulating hormone (FSH), control the ovaries, the 
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female gonads. (The word “gonad” simply means an organ that produces reproductive 
cells-eggs or sperm.) 
The chemical messenger, GnRH alerts the appropriate region of the pituitary 
gland, geographically a close neighbor of the hypothalamus, to secrete its hormones, LH 
and FSH. The hormones from the pituitary will in turn stimulate the ovaries. The FSH 
does just what its name suggests: it stimulates the follicles to develop. The LH, whose 
presence in the blood surges at midcycle, causes the dominant follicle to release the egg 
cell, culminating in ovulation. 
All of this regulation is governed by a control system called negative or reciprocal 
feedback, which works more or less like a thermostat. Within the body the regulating 
factors are chemical rather than thermal, but the principle is the same. There is a constant 
reciprocal feedback loop between the brain and the ovaries, and the brain continually 
responds to the levels of estrogen that it senses. For example, a lack of estrogen in the 
blood causes the LH and FSH to rise; this occurs during the menstrual cycle and also 
after the menopause. 
 
What Happens at Menopause 
The ovaries, as with many of the other organs, peak at some time in the late 
twenties or early thirties. Thereafter their production of estrogen and progesterone begins 
to decline gradually and finally stops all together. Researchers surmise that this has to do 
with the depletion of and finally the absences of follicles. It is estimated that women have 
five thousand to ten thousand follicles left when they are forty; the number declines 
precipitously after that. Researchers also know that with aging, either the follicles 
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become less responsive to the gonadotropins that formerly urged them to action or the 
smaller number of follicles started at each cycle results in lower estrogen and increased 
LH and FSH. 
At some point, most likely when woman are in their early forties, the menstrual 
cycle will probably become irregular in response to these declining estrogen and 
progesterone levels. Women will begin having occasional anovulatory periods; that is, 
periods in which no egg is released from a follicle. (The ovaries are producing enough 
estrogen to build up the endometrium, but not enough to fully mature a follicle.) Because 
ovulation does not occur, there is no corpus luteum to make progesterone. And because 
there is no progesterone, there is no way to stabilize the uterine lining nor is there a signal 
(the withdrawal of progesterone) for the shedding to take place in an orderly, controlled 
manner. Instead, the uterus lining keeps on building and building, eventually breaking 
down only because it outgrows its blood supply. 
Another scenario for menopause is that the ovaries may be producing some 
estrogen and progesterone, but not enough to keep the cycle going at its usual rate; the 
process may take longer than usual, and a woman may still have ovulatory cycles, but the 
periods may be more widely spaced. Sooner or later a woman will have her last period. A 
year afterward, it can safely be said that she is menopausal. 
 
Social and Psychological Changes That Occur in Menopause 
In Our Bodies, Ourselves: Menopause. The Boston Women’s Health Book 
Collective (2006) the social perceptions of menopause are discussed. In it the 
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writers discuss how menopause is viewed by society. “In popular media, 
menopause is often presented as a time of physical and mental  
degeneration that women dread. Women going through the transition are 
frequently portrayed as emotionally unstable and irrational-people who make 
break into tears for no reason, become angry without provocation, and seem „out 
of control‟” (p. 6).  
However, research suggests that emotional changes as part of menopause and its 
transition are not inevitable. The Massachusetts Women‟s Health Study, which is one of 
the largest and most comprehensive studies of women and menopause study, found that 
the vast majority of women have positive or neutral attitudes about menopause (Avis and 
McKinlay, 1995). Furthermore, in a 1998 Gallup survey sponsored by the North 
American Menopause Society, a majority of postmenopausal women said they were 
happier and more fulfilled than in times when they were younger. They reported 
improvements in their family and home lives, in partner relationships, and in   
friendships. In addition, approximately three-quarters of the women who lived in the 
United States and ranged in age from fifty to sixty-five, said they had made some type of 
health-related lifestyle change, such as stopping smoking, at menopause/midlife (Utian 
and Boggs, 1999).  
Fears and anxieties about menopause can be created, exaggerated, or manipulated 
by drug companies, media pundits, and self-help gurus who focus attention on the 
potential problems associated with menopause (and the supposed solutions they are 
selling) rather than provide a balanced and accurate picture of women‟s real experiences. 
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As Aged by Culture author Margaret Morganroth Gullette puts it, “Women have less to 
fear from menopause than from menopause discourse” (Morganroth Gullette, 2003). 
 Ski Hunter, Sandra Sundel, and Martin Sundel, in their book, Women at Midlife: 
Life Experiences and Implications for the Helping Professions, examined research to 
answer the following questions: Are menopausal women neurotic, grieving and 
depressed?  These are long-standing stereotypes resulting from the traditional biomedical 
view of menopause. Hence until recently, any emotional upset such as emotional 
instability or depression in a woman in her 40‟s or 50‟s was attributed to menopause 
(Clausen, 1986; Hallstrom & Samuelsson, 1985). This attribution, however, does not hold 
up in the face of empirical evidence. Although some women may experience a slight 
heightening of psychological distress during premenopause (Bromberger & Matthews, 
1996) and perimenopause (Hunter, 1990), there is no notable heightening of 
psychological distress in menopausal or postmenopausal women (Hunter, 1990; 
Matthews et al., 1990; Stewart, Boydell, Derzko, & Marshall, 1992). In a nationally 
representative sample of midlife women, Busch, Zonderman, & Costa (1994) obtained 
reliable and valid measures of psychological distress during two interviews with these 
women over a ten-year period. The results provided evidence that menopausal status was 
unrelated to psychological distress. No upsurge happened in depression, psychological 
well-being, or sleep disturbance. When compared with premenopausal women, neither 
perimenopausal nor postmenopausal women reported any greater psychological distress. 
Many women believe that menopause causes depression (Matthews, Kuller, 
Wing, & Meilahn, 1994; Daly, 1995). Yet representative samples and longitudinal studies 
have not found evidence that psychological distress is associated with menopause 
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(Dennerstein, Dudley, Guthrie, & Barrett-Connor, 2000). Studies do not find that 
menopause causes depression or that depression is especially prevalent at menopause 
(Hallstrom & Samuelsson, 1985; Utian, 1989). 
 The absence of a link between menopause and depression was strongly reinforced 
in the longitudinal studies on menopause. Most of these studies included a measure of 
depression. The Manitoba Project, a longitudinal study that examined the link between 
depression and menopause, found that depression was not related to the menopausal 
transition (Kaufert, Gilbert, & Tate, 1992). Depression was associated with surgical 
menopause but not with natural menopause in the Massachusetts Woman‟s Health Study 
(McKinlay & McKinlay, 1987). Depression was not associated with biological changes 
either before the transition to menopause, during the transition, or after menopause. The 
Healthy Women Study, a population-based, prospective, cohort study, found that a 
temporary heightening of depressed mood was reported during the menopausal transition 
(Avis, Brambilla, & McKinlay, 1994). This change, however, was only indirectly 
associated with the transition itself through signs such as hot flashes and night sweats. 
Other associations with depressed mood included a longer transition to menopause,  prior 
depression, health difficulties, and social circumstances such as multiple, conflicting 
roles (McKinlay, Brambilla, & Posner, 1992). The South East England Study, a 
longitudinal study of depression and menopause, found that women who were depressed 
attributed the condition not to menopause but to family difficulties, bereavement, 
financial worry, work, and illness. Menopausal depressed mood was predicted by 
premenopausal depressed mood, stereotypes about menopause, unemployment, low 
social class, stress, and lack of exercise (Hunter, 1990b, 1992). Menopause was only 
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modestly associated with depression in the Norway study (Holte & Mikkelsen, 1991; 
Holte, 1992); a prospective study of healthy Norwegian women, found that more 
important predictors of depression included earlier responses to menstruation, negative 
expectations of menopause, and mother‟s perimenopause complaints. 
 The frequency of prior depression found in the longitudinal studies indicates that 
psychological distress is a stable characteristic over the lifetime. If women report 
psychological distress at menopause, they are likely to have previous episodes of distress, 
such as anxiety or depression (Costa, et al.1987; Matthews, et al., 1990). The strongest 
predictor of depression in the Healthy Women Study was prior depression (Avis et al., 
1994). The Norway study also reported continuity of signs of depression over the life 
course. Women who experienced depressed mood consistently reported more stress and 
were more likely to have a history of premenstrual symptoms (PMS) and postpartum 
blues than women with an absence of depression (Woods & Mitchell, 1996). The 
researchers cautioned that these women may be at risk for continuing difficulties with 
depression and may require intensive counseling with a focus on managing and 
preventing depression. 
 The key conclusion from the longitudinal studies on menopause is that there are 
no adverse effects of the menopausal transition on mental health, including depression. 
Menopause itself does not create psychological vulnerability (Bromberger & Matthews, 
1996). 
 In addition to psychosocial factors that may affect one‟s mood, negative beliefs 
about the effects of menopause can also lead to a depressed mood (Hunter, 1992; Liao & 
Hunter, 1995). One source of negative beliefs is negative symbolism associated with the 
HYPNOSIS AND MENOPAUSE  19 
changes in a woman‟s body or the way in which a woman interprets them (Bart, 1972; 
McKinlay, et al., 1987). She may abhor the whole idea of menopause because she sees it 
as a sign of old age, that she is no longer attractive, or even that she is useless (Stimpson, 
1982; Wilk & Kirk, 1995). She may feel a loss of control over her body, and generally, 
over what is happening in her life (Stimpson, 1982). Negative reactions can also result 
from identification with a mother who experienced a difficult midlife and menopausal 
transition (Cate & Corbin, 1992). Woods and Mitchell (1996) noted that a woman who 
experienced negative socialization regarding midlife exhibited a pattern of depression 
that they termed as “emerging depressed mood” (EDM). Compared with women who did 
not experience depression at midlife, the EDM women were also more likely 
characterized by “a history of PMS, poorer health status…fewer family resources, and 
less social support” (Woods & Mitchell, 1996, p. 121). During the first year of a two-year 
study, these women scored below the depressed mood level but they scored above that 
level in the second year. Fortunately, for some women who had negative expectations 
about menopause, the actual experience of menopause resulted in a more positive attitude 
(Avis et al., 1994). If this change did not occur, Woods and Mitchell (1996) suggested 
that negative socialization and lack of positive social support may be modifiable through 
psychoeducational programs that provide accurate information about midlife and 
menopause, may inspire positive attitudes, and may provide connections with other 
women experiencing similar midlife challenges.  
 Given some exceptions, most women report neutral or positive attitudes about 
menopause (Avis & McKinlay, 1991; Hunter, 1992). Instead of being a “syndrome” or 
major event causing health and mental health difficulties, menopause is more truly a 
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nonevent. If anything, there are gains from menopause, such as simply not menstruating 
anymore. With no worry about pregnancy, a woman‟s sex life may be revitalized 
(Perlmutter & Bart, 1982; Schlossberg, 1986; Chiriboga, 1989). Relief about not having 
to worry about pregnancy is far more commonly experienced than is despair over no 
longer being able to bear children (Clausen, 1986).  
 The situation for midlife lesbians is also positive. Cole and Rothblum (1990) 
conducted the first empirical survey of lesbian women at menopause with a nonclinical 
sample. They asked the respondents about positive changes in their lives relative to 
menopause. Aside from the cessation from menstruation, positive changes included more 
sex, more orgasms, greater self-acceptance, and enjoyment of their maturity. Only 22 
percent of the sample indicated that they experienced no positive changes following 
menopause. 
 
Sociocultural Changes That Occur in Menopause 
We cannot fully understand the psychological effects of menopause without 
knowing, apart from the biological changes occurring in a woman‟s body, how different 
cultures treat this transition. If anything causes discomfort, it may be, for example, social 
circumstances, role changes, negative expectations, and negative cultural attitudes about 
aging women and menopause. 
What women anticipate during the menopausal transition can influence the 
results. During the baseline measures of attitudes in several longitudinal studies, some 
respondents reported that they thought women became depressed or irritable during 
menopause. These same women were significantly more likely at follow-up to report 
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depression, irritability, and troubles with hot flashes, night sweats, and/or insomnia. 
Women at baseline who rejected negative views were much less likely to show any 
negative signs of menopause (Avis, Brambilla, McKinlay, & Vass, 1994; Woods & 
Mitchell, 1999). Bareford (1991) also found that midlife women reported more negative 
signs when they held more negative attitudes about menopause and when they 
experienced more difficult life events. Educational intervention, however, may reduce the 
negative attitudes. Liao and Hunter (1998) evaluated a short-term health education 
intervention (at three and 15 months) that provided information and group discussion 
about the normal menopausal transition. The women in this study reported fewer negative 
beliefs about menopause following the intervention. 
Menopause, therefore, does not have to be a negative biological, social, or 
psychological event. When there are uncomfortable signs of menopause, such as hot 
flashes, women should have a variety of treatments available to them. It is informative to 
observe or examine the various traditional and nontraditional treatments for menopause. 
 
Traditional Treatments for Hot Flashes 
  Before HRT, the treatments for hot flashes, or any of the symptoms of 
menopause, were few and far between. In fact, as Gail Sheehy pointed out in her book, 
The Silent Passage (1991) the following:  
Gynecologists by and large find the menopausal woman an unappealing patient. 
She isn‟t going to have any more babies. Apart from a hysterectomy, there is little 
chance  that she will require surgery – the moneymaking part of the practice – but 
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she can be expected to complain about vague symptoms and ask questions for 
which even the sympathetic physician has only unsatisfactory answers. (p. 36)  
The treatments for menopause were often surrounded by folklore and old wives 
tales. For example, in her book The Greatest Experiment Ever Performed on Women, 
Barbara Seaman quotes the following from an Egyptian Medical Text in 2000 BC: “If a 
menopausal woman has pain or makes trouble, pound her hard in the jaw”. She further 
reports that more than five hundred years ago, a medical book from the Renaissance 
Europe recommended that the woman having problems in menopause receive “a 
decoction of myrrh and apples.”  If that was not successful, “a cure may sometimes also 
be affected by pouring some of this same substance into her sandals, and urging the 
patient to walk” (p. 7). In her book, Hot and Bothered: Women, Medicine, and 
Menopause in Modern America, Judith A. Houck, assistant professor of medical history, 
bioethics, and history of science and women‟s studies writes: 
One hundred years ago, menopause barely attracted either medical or cultural 
notice. As the 20th century got under way, menopause was feared more for what it 
could do to a woman‟s nerves than for what it could do to her body. By mid-
century, many regarded it as a threat to domestic life, as women became cranky 
with their families and uninterested in maintaining their physical appearance. By 
the 1970‟s, once common construction of menopausal women characterized them 
as diseased, desexed, depressed and decayed. As this shift occurred, treatment 
protocols changed.  
Until the 1940‟s, most doctors seemed to advise their menopausal patients to quit 
worrying and take up a hobby, Houck says. After the 1940‟s, sedatives and short-term 
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hormone therapies emerged as possible additions to advice and reassurance. “In the late 
1960‟s and „70‟s, the „disease‟ model of menopause became more widespread. As a 
result, both long-term and short-term use of estrogen therapy increased,” Houck adds. A 
critical catalyst in this evolution was a paper that Brooklyn gynecologist Robert A. 
Wilson published in 1963. The paper later became the best-selling 1966 book “Feminine 
Forever,” which presented menopause as “living decay,” a hormonal deficiency that 
should be treated with estrogen replacement therapy (ERT).  
The science of hormone replacement has been in continual evolution since 
estrogen replacement was introduced initially in 1949 and the first birth control pills hit 
the market in the 1960‟s (Northrup, 2001). The pill, for the first time, gave women the 
ability to alter their natural hormonal and fertility rhythms. Women could choose, with a 
greater accuracy, when or whether they would have children. Unfortunately, as Dr. 
Northrup writes in her book The Wisdom of Menopause (2001):  
The downside is that these rhythms and the natural wisdom that created them have 
become pathologized, leading women to believe that synthetic, man-made 
hormones are safer and better than the “unpredictable” ones found naturally in our 
bodies. Conventional hormone replacement is an extension of this thinking: that 
the female body is deficient and needs to be fixed. (p.137)  
The traditional medical treatment for menopause symptoms involves hormone 
replacement therapy (HRT). HRT is a treatment that is used to supply the body either 
with estrogen alone or estrogen with progesterone combination. Estrogen and 
progesterone are hormones that are naturally produced by a woman‟s ovaries. When the 
ovaries no longer produce adequate amounts of these hormones (as in menopause) 
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hormone therapy can be given to supply the body with adequate levels of estrogen and 
progesterone (webMD Health, 2004). HRT may be delivered to the body via patches, 
tablets, creams, troches, IUDs, vaginal rings, gels or, more rarely, by injection. Dosage is 
often varied cyclically, with estrogens taken daily and progesterone or progestins taken 
for about two weeks every month or two (www.wikipedia.org). Estrogen became 
commercially available in the 1930‟s, and in 1942 the federal Food and Drug 
Administration approved Premarin, to relieve hot flashes (Minkin and Wright, 2004). 
Premarin is a patented drug made up of conjugated estrogens obtained from the urine of 
pregnant mares (PREgnant MARes‟ urINe, or PMU). Manufactured exclusively by 
Wyeth-Ayerst at Ayerst Organics Limited in Brandon, Manitoba, Canada, Premarin is 
Canada‟s most lucrative pharmaceutical export to date. It is the most widely prescribed 
drug in the United States and holds 80% of the estrogen supplement market worldwide. 
In the „90‟s Premarin had become the drug of choice for hormone replacement therapy. 
Some estimates claim that close to nine million women are currently taking 
Premarin (about a third of the thirty million plus post menopausal women in the United 
States are on estrogen replacement therapy, and of them, about 80% use Premarin). 
Wyeth‟s revenues from Premarin are currently $1billion a year and rising 
(http://www.project-aware.org/Managing/Hrt/PremarinFacts_Opinion.shtml). 
As previously noted, women and their doctors became concerned about the use of 
HRT for menopause because of many risks associated with their use. In recent years, 
numerous observational studies have been reported regarding various issues associated 
with HRT and its risks and benefits in preventing chronic disease. Until 2001, the belief 
that HRT provided benefits in relation to heart disease was widely accepted and the risks 
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associated with short- or long-term hormone therapy in terms of breast cancer were 
largely unknown. However, in 2001 and 2002, two randomly controlled studies found 
that HRT caused adverse events in women already diagnosed with heart disease, as well 
as in women not yet diagnosed with heart disease. In the Heart and Estrogen/Progestin 
Replacement Study (HERS), use of HRT in women with established heart disease was 
found to be ineffective in preventing the progression of coronary artery disease, 
especially when cardiac medications or lipid-lowering drugs were already being used 
(Hulley, Grady, Bush, and Furberg, 1998). 
In the more recent Women‟s Health Initiative Randomized Control Study (WHI), 
sponsored by the National Institutes of Health (NIH), a large, randomized clinical trial of 
over 16,000 healthy women ages 50 through 79, in which half of the participants took 
hormones and the other half took a placebo pill, was halted early; in July 2002, 
investigators reported that the overall risks outweighed the benefits. The WHI found that 
the use of HRT increases the risk of breast cancer, heart disease, stroke, and blood clots. 
The incidence of breast cancer increased by 26% for women in the HRT group. The risk 
of breast cancer begins to increase after two years of HRT and the risk of cardiovascular 
disease increased shortly after hormones were started. Similar findings were shown in the 
first year of the study in women with no diagnosis of heart disease. Participants on the 
combined hormone arm of the study showed an increased risk for cardiac events in the 
first 5 years of the study (Writing Group for the Women‟s Health Initiative Investigators, 
2002). Critics of these studies have pointed out that HRT and primary prevention of heart 
disease were not studied because the average age of the participants in the HERS trial 
was 67 years at baseline and in the WHI, 63 years at baseline. The studies did show that 
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HRT can have deleterious effects on older women who already have risk factors for heart 
disease. Because participants were older at the start of the study, critics determined that it 
did not thoroughly investigate primary prevention with HRT started in younger women at 
the time of menopause (Karas, and Clarkson, 2003). Although findings in the WHI study 
showed a low but modest increased risk for breast cancer in women on the combined 
hormone regimen, there was no increased risk for breast cancer in the unopposed 
estrogen arm of the study (Writing Group for the Women‟s Health Initiative 
Investigators, publication in process). Data from many observational studies suggest that 
HRT, when taken long-term, modestly increases the risk for breast cancer (Collaborative 
Group on Hormonal Factors in Breast Cancer, 1997; Colditz, 1998; Schairer, Lubin, and 
Troisi, 2000; Bush, Whiteman, and Flaws, 2001).  
Further findings from the WHI study showed a reduction of risk for hip fracture in 
women on HRT. This was the first, randomized control trial supporting findings from 
previous observational studies demonstrating the efficacy of HRT for stabilizing bone 
after menopause (Vestergaard, Herman, and Gram, 1997; Writing Group for the 
Women‟s Health Initiative Investigators, 2002). In addition, the WHI showed a 
significant reduction in risk for colon cancer for those women on combined HRT, 
supporting previous findings in studies investigating HRT and colon cancer (Vestergaard, 
Herman, and Gram, 1997; Writing Group for the Women‟s Health Initiative 
Investigators, 2002). 
WHI researchers have found that estrogen plus progestin does not protect but may 
increase the risk of heart disease among generally healthy postmenopausal women. The 
study also showed that women who were studied doubled the combined rate of blood 
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clots in the lungs and legs, a 41 percent increase in the incidence of strokes, and gall 
bladder disease (Writing Group for the Women‟s Health Initiative, 2002).  
A study related to HRT and its role in the cognitive function and prevention of 
Alzheimer‟s was recently reported (Shumaker, Legault, and Rapp, 2003). In this study, 
known as the Women‟s Health Initiative Memory Study (WHIMS), women aged 65 
years and older taking combined HRT were found to have doubled the risk of developing 
dementia as compared with the placebo group within the same age range. Critics of this 
study point to the advanced age of the women in the study group and limited application 
of the findings to younger women taking HRT during the menopause transition. Data 
from past observational studies, such as the Cache County Study, have shown a 
significant reduction in risk for Alzheimer‟s in women who initiated HRT during the 
menopause transition, and had taken HRT for more than 10 years (Zandi, Carlson, and 
Plassma, 2002)  
Additionally, an analysis of the quality of life of a subgroup of WHI participant‟s 
ages 50 through 79 found no change in general health, vitality, mental health, depressive 
symptoms, or sexual satisfaction associated with use of estrogen plus progestin (Hays, 
Ockene, and Brunner, 2003). The results were similar to results found in the HERS study 
(Hlatky, Boothroyd, and Vittinghoff, 2002), showing no improvement in quality of life in 
older, postmenopausal women starting HRT. Critics of both of these studies point to the 
later age of the study participants. In the case of the WHI study, women who were 
experiencing menopausal symptoms were dissuaded from participating in a randomized 
study in which they could possibly be given a placebo. In addition, progestin, one of the 
study drugs used in the WHI and HERS trials, has some known side effects including 
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mood swings, breast tenderness, and uterine bleeding. There have been numerous 
observational studies reporting benefits from HRT in symptomatic menopausal patients. 
However, it has also been found that it is most often healthy, upper middle class women 
who tend to take HRT for any length of time (Brett and Madans, 1997). Whether or not 
the results from the HERS or WHI studies can be extrapolated to other known forms of 
HRT is unclear.  
In another large study, designated the “Million Women Study”, current users of 
HRT were more likely to develop breast cancer. Risk was seen with almost all estrogen 
preparations, but the magnitude was significantly greater for estrogen combined with 
progesterone (Beral, 2003). 
  
Nonhormonal Medical Treatment for Hot Flashes 
The North American Menopause Society (NAMS) is the leading nonprofit 
scientific organization devoted to promoting women‟s health and quality of life through 
an understanding of menopause. They reviewed the evidence obtained from the medical 
literature to look at the effectiveness of some nonhormonal medical treatments, including 
antidepressants such as venlafaxine, paroxetine, fluoxetine, and gabapentin. According to 
the review, certain prescription antidepressants may decrease hot flashes in women, 
including those with a history of breast cancer. This effect on hot flashes most likely 
results from alterations of central serotonin or norepinephrine concentrations. Serotonin, 
injected into the hypothalamus, widens the thermoneutral zone in rats and guinea pigs; no 
human data are available. A review of the data for three antidepressants follows.  
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 Venlafaxine. One antidepressant investigated for treating menopause-related hot 
flashes is venlafaxine HCl, a combined serotonin and norepinephrine reuptake inhibitor 
(SNRI). A randomized, double-blind, placebo-controlled clinical trial (Loprinzi, Kugler, 
and Sloan, 2000) enrolled 229 women who were experiencing at least 14 hot flashes per 
week (69% were taking tamoxifen) and either had a history of breast cancer or chose not 
to take ET/EPT. Women were randomized to 4 weeks of treatment either with a placebo 
or with one of three venlafaxine doses: 37.5, 75, or 150 mg/day. At the end of the study, 
venlafaxine recipients had hot flash score reductions from baseline of 37% for the 37.5-
mg/day dosage and 60% for both higher doses, as compared with a 27% reduction for 
placebo recipients. The effect on reducing hot flashes was relatively rapid, with full effect 
noted within 1 to 2 weeks. An uncontrolled pilot trial also supports this finding (Loprinzi, 
Pisansky, and Fonseca, 1998). 
In the clinical trial, venlafaxine was relatively well tolerated at doses of up to 150 
mg/day. Doses used to treat depression start at 75 mg/day and increase to150 to 225 
mg/day. The most problematic side effect was nausea or vomiting, which led to drug 
discontinuation in 5% to 10% of women, depending on the dose. In women who 
developed nausea but continued therapy, nausea largely dissipated over the following 1 to 
2 weeks. In addition, those taking venlafaxine had more dry mouth and a decreased 
appetite. Only the highest dose arm had greater degrees of constipation than the placebo 
arm. 
Contraindications to using venlafaxine include concomitant use with MAO 
inhibitors. Other adverse effects observed in venlafaxine trials for depression include 
somnolence, dizziness, constipation, and sexual dysfunction. There is also a dose-related 
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risk of increased blood pressure with the use of venlafaxine, affecting about 3% of those 
using less than 100 mg/day (Wyeth Pharmaceuticals, 2003).  
 
 Paroxetine. A selective serotonin-reuptake inhibitor (SSRI), paroxetine HCl has 
also been associated with decreased hot flash rates. The only randomized, double-blind, 
placebo-controlled trial used controlled-release paroxetine in 165 women without a 
history of breast cancer who were experiencing 2 or 3 hot flashes per day (Stearns, 
Beebe, Iyengar, and Dube, 2003). At doses of either 12.5 or of 25.0 mg/day for 6 weeks, 
paroxetine significantly decreased hot flash composite scores by 62.2% (12.5 mg/day) 
and 64.6% (25.0 mg/day), compared with a 37.8% decrease for placebo recipients. 
Results from two uncontrolled pilot studies also support this study (Weitzner, Moncello, 
Jacobsen, and Minton, 2002; Stearns, Isaacs, and Rowland, 2000). 
Contraindications to using paroxetine include concomitant use of MAO inhibitors 
or thioridazine. Caution is advised with concomitant administration of warfarin. Adverse 
effects observed in trials for depression include asthenia, sweating, nausea, decreased 
appetite, somnolence, insomnia, and dizziness. The recommended initial dose for treating 
depression is 20 mg/day. 
 
 Fluoxetine. Another SSRI, fluoxetine HCl, is government approved to treat 
depression and premenstrual dysphoric disorder, but it also has been studied as an 
antidote for hot flashes at the same dose (20 mg/day) that has been recommended as the 
initial dose to treat depression. In a double-blind, placebo-controlled, crossover trial 
(Loprinzi, Barton, and Sloan, 2002), 81 healthy women with a history of breast cancer or 
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a perceived risk of breast cancer who had at least 14 hot flashes per week were 
randomized to fluoxetine (20 mg/day) or placebo for a 4-week period, with the alternative 
treatment given for an additional 4 weeks. The crossover analysis found additional 
reductions in hot flash frequency of about 20% for fluoxetine recipients compared with 
placebo recipients (no difference in results based on age). The magnitude of benefit in 
this study, however, did not seem to be as great as was seen with venlafaxine. Fluoxetine 
was well tolerated in this trial. 
 
 Gabapentin. This anticonvulsant has been studied for treating hot flashes. Its 
mechanism of action on hot flashes is unknown, although it has been speculated that 
gabapentin may modulate calcium currents. 
A randomized, double-blind, placebo-controlled trial performed in 59 
postmenopausal women averaging seven or more hot flashes per day found that, after 12 
weeks of gabapentin therapy (900 mg/day, administered in three divided doses), hot flash 
frequency was reduced by 45%, with a 54% reduction in a hot flash composite score 
(Guttuso, Kurlan, McDermott, and Kieburtz, 2003). The differences were statistically 
significant compared with placebo recipients, who had reductions of 29% and 31%, 
respectively. Gabapentin was relatively well tolerated in this clinical trial, with dizziness 
and lightheadedness (especially at initiation of therapy) and peripheral edema being the 
major observed adverse effects. Results from a prospective, single-arm study (Loprinzi, 
Barton, and Sloan, 2002) and an open-case series (Albertazzi, Bottazzi, and Purdie, 2003) 
also support these findings. 
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Although higher doses of gabapentin are commonly used for treatment of seizures 
or neuropathies (up to 3,000–3,600 mg/day), doses as low as 100 mg/day are typically 
used as starting doses for hot flashes; this particularly true for older women. 
Hypersensitivity to the drug is the only contraindication to gabapentin use. Adverse 
effects observed in seizure trials include somnolence, dizziness, ataxia, fatigue, and 
nystagmus. 
 
 Antihypertensives. Two older antihypertensive drugs, clonidine HCl and 
methyldopa HCl, have been studied for treating hot flashes. 
 
Clonidine. Two randomized, placebo-controlled trials (N = 10 and N = 29) found 
that the [alpha] 2-adrenergic agonist clonidine, given either orally or transdermally, 
reduced hot flash frequency by 46% (for 0.4 mg/day) and 80%, respectively, in healthy 
women (Laufer, Erlik, Meldrum, and Judd, 1982; Nagamani, Kelver, and  Smith, 1987). 
However, in one of these studies, (Laufer et al., 1982) four women in the clonidine group 
withdrew because of drug-related side effects, which included nausea, fatigue, headaches, 
dizziness, and dry mouth. 
In breast cancer survivors using tamoxifen, two randomized, placebo-controlled 
clinical trials also found clonidine effective in relieving hot flashes (Goldberg, Loprinzi, 
and O‟Fallon, 1996; Pandya, Raubertas, and Flynn, et al., 2000). An 8-week trial (Pandya 
et al., 2000) found that oral clonidine (0.1 mg/day) significantly reduced hot flashes in 
194 postmenopausal women (by 38% v 20% for placebo), although the clonidine group 
reported more difficulty sleeping than those receiving placebo (41% v 21%, 
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respectively). In 110 women (median age, 54) (Goldberg et al. 1996), transdermal 
clonidine (equivalent to 0.1 mg/day) for 4 weeks significantly decreased hot flash 
frequency and severity compared with placebo. However, clonidine was associated with 
more side effects than the placebo, including dry mouth, drowsiness, constipation, and 
itchiness under the patch.  
The exact mechanism of action is unknown, but it is thought to relate to 
clonidine‟s ability to reduce vascular reactivity (Goldberg et al., 1996). Contraindications 
include cardiac sinus node function impairment. Clonidine lowers blood pressure, heart 
rate, and pulse rate; arrhythmias have been observed at high doses. Adverse effects 
observed in hypertension trials include dry mouth, drowsiness, dizziness, constipation, 
and sedation. 
 
Methyldopa. Two randomized, double-blind, placebo controlled, crossover trials 
reported that methyldopa, in daily oral doses of 500 to 1,000 mg, decreased menopause-
related hot flashes, although improvement was modest (Hammond, Hatley, and Talbert, 
1984; Nesheim and Saetre, 1981). Nesheim and Saetre (1981) reported a median 
reduction in hot flashes of 65% with methyldopa (250 mg/day), compared with 38% for 
placebo, a significant between-group difference. Hammond et al. (1984) found significant 
reductions in hot flashes in a trial involving 10 women. 
Contraindications include active hepatic disease and use of MAO inhibitors. 
Methyldopa lowers blood pressure. A positive Coombs test, hemolytic anemia, and liver 
disorders may occur with methyldopa therapy. Side effects observed in hypertension 
trials include sedation, headache, asthenia, edema, and weight gain 
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 Bellergal Spacetabs. There are limited data to support the efficacy of this older 
sedative, a combination tablet of low-dose phenobarbital (a barbiturate), ergotamine 
tartrate, and levorotatory alkaloids of belladonna, in treating menopause-related hot 
flashes. Its specific mechanism of action is unknown. 
A randomized, double-blind, placebo-controlled study in 72 women found that 
Bellergal significantly reduced hot flashes, compared with placebo (60% v. 22%, 
respectively) after 12 weeks of treatment (Lebherz and French, 1969). In a randomized, 
placebo-controlled, double-blind trial of 66 women, (Bergmans, Merkus, Corbey, 
Schellekens, & Ubachs, 1987) significant decreases in hot flashes from baseline were 
reported after 8 weeks for both the Bellergal (75%) and placebo (68%) groups. However, 
the between-group difference was not significant. 
Contraindications include cardiovascular or hepatic disease and glaucoma. 
Adverse effects include visual disturbances, dry mouth, flushing, dizziness, and 
somnolence. Bellergal reduces the efficacy of certain drugs, including anticoagulants and 
OCs. Bellergal intoxication can lead to death. Barbiturates are addictive and should not 
be recommended for long-term use. 
In its review, NAMS adds that no therapy is government approved either in the 
United States or in Canada for treating hot flashes in women who are at high risk for or 
have been diagnosed with breast cancer or other hormone-dependent neoplasias.  
In another review published in the journal of the American Family Physician 
(2006), Carroll observed nonhormonal therapies for hot flashes in menopause. She found 
that studies of selective serotonin reuptake inhibitors (SSRIs) and venlafaxine (Effexor), 
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a serotonin and norepinephrine reuptake inhibitor, have shown an absolute risk reduction 
(ARR) in hot flashes of 19 to 60 percent with these agents, compared with placebo 
primarily in women with a history of breast cancer (Evans, Pritts, Vittinghoff, McClish, 
Morgan, and Jaffe, 2005; Stearns, Beebe, Iyengar, and Dube, 2003; Weitzner, Moncello, 
Jacobsen, and Minton, 2002; Barton, Loprinzi, Novotny, Wilwerding,  and Sloan, 2002; 
Loprinzi, Kugler, Sloan, Mailliard, LaVasseur, and Barton, 2000; Stearns, Isaacs, 
Rowland, Crawford, Ellis, and Kramer, 2000; Loprinzi, Sloan, Perez, Quella, Stella, and 
Mailliard, 2002; Loprinzi, Pisansky, Fonseca, Sloan,  Zahasky, and Quella, 1998 ). Two 
studies involved women who did not have a history of breast cancer. In one study 165 
postmenopausal women were randomized to receive controlled-release paroxetine (Paxil 
CR) in a low or high dosage or a placebo. Participants experienced reductions in hot flash 
scores of 37 percent in the placebo group, 62 percent in the low-dosage group, and 65 
percent in the high-dosage group (P < .001) (Stearns et al., 2003). In a study of 80 
postmenopausal women receiving extended-release venlafaxine (Effexor XR) or a 
placebo for 12 weeks, the participants reported decreases in hot flash scores of 51 and 15 
percent, respectively (Evans et al. 2005). However, the U.S. Food and Drug 
Administration (FDA) withdrew Paxil CR from the market in March 2005 because of 
concerns regarding its manufacturing quality.  
Most of the studies reported transient, dose-related adverse effects. The most 
common adverse effects reported were insomnia or excitement, nausea, constipation, and 
anorexia (Stearns et al., 2003; Loprinzi, Kugler et al., 2000; Loprinzi, Sloan et al., 2002) 
In the trials using venlafaxine for hot flashes, there were no reported increases in blood 
pressure, which is a dose-related adverse effect commonly associated with this agent 
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(Barton et al, 2002; Loprinzi et al., 1998). The dosage and duration of these medications 
most appropriate in alleviating hot flashes is unknown; however, regimens using low to 
moderate dosages seem to be as effective as those using high dosages and they have 
significantly fewer reported adverse effects. Therefore when using an SSRI or 
venlafaxine to treat hot flashes, it is prudent to initiate the medication at a low dosage and 
titrate to effect. 
The exact mechanism of action by which these medications alleviate hot flashes is 
unknown, although hot flashes have been linked to an imbalance in serotonin. (Stearns, et 
al., 2003; Berendsen, 2000; Loprinzi, et al., 1998). 
 
Alternative Treatments for Hot Flashes 
With the growing concerns of HRT for hot flashes, the Women‟s Health Initiative 
influenced many women to discontinue estrogen therapy and to explore alternative 
treatments, such as botanical medicine and dietary supplements (Messina, 2002). The 
National Center for Complementary and Alternative Medicine at the National Institutes 
of Health defines alternative therapies as “those treatments and health care practices not 
taught widely in medical schools, not generally used in hospitals, and not usually 
reimbursed by medical insurance companies”.  
Consumer demand, coupled with the support of the US Congress, has led to two 
defining events that have increased the acceptability and legitimacy of complementary 
and alternative medicine in the United States. In 1992, the office of Alternative Medicine 
was started as a branch of the National Institutes of Health, with minimal funding of $2 
million dollars. Today, the National Institutes of Health invests over $200 million 
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annually in research on alternative therapies and the National Center for Complementary 
and Alternative Medicine, with a budget of $89 million, has become a major provider of 
funding for research on CAM practices. Moreover, the Congress passed the Dietary 
Supplement Health and Education Act, which exempts botanical medicines from drug 
regulatory processes by classifying them as dietary supplements. Supplements can be 
sold neither with oversight nor with testing by the Food and Drug Administration.  
An article published in the New England Journal of Medicine in 1993 described 
the enormous impact of alternative medicine on health care in the United States. The 
authors reported that in 1990 Americans made 425 million visits to alternative providers, 
such as chiropractors, massage therapists, acupuncturists and naturopathic physicians, for 
charges totaling $12 billion. The number of CAM providers is expected almost to double 
between 1997 and 2010, meaning that a decade from now there will be one CAM 
provider for every six medical doctors. According to a nationwide government survey 
released in May 2004, 36 percent of U.S. adults aged 18 years and over use some form of 
complementary and alternative medicine. When prayer, specifically for health reasons, is 
included in the definition of CAM, the number of U.S. adults using some form of CAM 
in the past year rises to 62 percent (http://nccam.nih.gov/news/camstats.htm). 
In 2000, the retail sales of natural products in the United States surpassed $15 
billion, (National Nutritional Foods Association Northwest Region) with sales of 
products for treating menopause symptoms accounting for approximately $600 million 
(Kass-Annese, 2000). However, there is not much evidence that these “alternative” 
treatments are beneficial (Quella et al., 2000; Barton et al., 1998; Pandya et al., 2000; 
Kronenberg & Fugh-Berman, 2002).  
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Millions of dollars are spent on over-the-counter products for menopausal 
symptoms by women who have little knowledge of their quality, safety, or effectiveness. 
The 25 million women who will move through menopause during the next decade face an 
increasingly complex array of alternative therapies for their symptoms (Woods, 1999).  
The most recognizable and widely used CAM treatment is botanical medicine, 
which is the use of plants or plant extracts for medicinal purposes. A review by Taylor 
(2002) looked at evidence-based alternative treatments for hot flashes.  
 
 Soy. Studies of soy for menopausal women are mixed. The outcomes are difficult 
to compare because of different amounts of soy protein in differing food stuffs with 
different amounts of the active component, the isoflavones. Moreover, studies have been 
of very short duration, fewer than 3 months. Representative studies include Washburn, 
Burke, Morgan, and Anthony (1999), during which women were given 20 g of soy 
protein with 34 mg of isoflavones or a 20-g carbohydrate complex for 1.5 months. Hot 
flashes decreased in severity but not in frequency in the treatment group. Albertazzi, 
Pansini, Bonaccorsi, Zanotti, Forini, and De Aloysio (1998) studied more than 100 
women with seven or more hot flashes per day, and randomized them to a 60-g soy 
protein supplement with 76 mg of isoflavones or to a casein control. Hot flashes 
decreased by 45% in the treatment arm, compared with only a 30% decrease in the 
control group. In another study, women were given a soy flour supplement (Scambia, 
Mango, Signorile, Anselmi, Palena, and Gallo, 2000). After 3 months the soy group 
evidenced a 40% reduction, whereas the controls fed wheat flour experienced about a 
25% decline. The difference was not significant. 
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 Knight, Howes, Eden, and Howes (2001) conducted a randomized, double-blind, 
placebo-controlled, parallel-group trial with 24 postmenopausal women. After 3 months 
of treatment, women on a dietary beverage with 60 g of soy protein with a total 
isoflavone concentration of 134.4 mg were compared with a control group ingesting the 
same shake but an isoflavone-poor version. There were no observed differences in the 
responses of subjects in hot flashes. The soy group had a 25% drop-out rate from the 
study because of bad taste. Other studies have also had very high discontinuation rates in 
the soy arms because of gastrointestinal distress, gas, cramps, and stomach pains.  
 Other studies conducted to investigate the use of soy supplements for hot flashes 
found that soy was less effective than a placebo (Quella et al., 2000), or than vitamin E 
(Barton et al., 1998). Kronenberg & Fugh-Berman, 2002, found that soy does not seem to 
be much more effective, or only modestly more effective than placebo. 
 
 Black cohosh.  Black Cohosh (Cimicifuga racemosa L. Nutt, family, 
Ranunculaceae) goes by many folk names including black snakeroot and bugbane. Before 
the recognition of a potential link between estrogen and breast cancer, the basic science 
research of the manufacturer sought to prove that black cohosh had estrogenic activity. 
The company, however, took a different tack after 1990, trying to characterize black 
cohosh as something other than estrogen. 
Quality clinical trials are limited. Seven of eight published trials did not use 
placebo controls and seven of eight are available only in German. Duker, Kopanski, 
Jarry, and Wuttke (1991) conducted a comparison of black cohosh with a placebo using 
40 mg twice daily (twice the standard dose) and found that Remifemin suppressed hot 
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flashes about 25% better than the placebo in the 2-month trial. Another trial compared 
this product, 40 mg twice daily, with conjugated equine estrogen, 0.625 mg, and with a 
placebo. The herbal remedy provided good relief, whereas estrogen, surprisingly, 
performed no better than a placebo. Closer scrutiny may explain this apparent 
contradiction to the basic understanding of the role of hormone replacement therapy. 
Another study by Lehmann-Willenbrock and Riedel (1998), which includes women 
presumed in many review articles to be menopausal, involved 60 subjects under the age 
of 40, posthysterectomy. This study is highly flawed as a proof of the efficacy of black 
cohosh in menopausal women. The women in this study were said to be post menopausal. 
Careful reading, however, reveals that all subjects had their uterus removed; however, 
one or both ovaries were retained. Given the fact that all women were under the age of 
40, almost all would also retain a high potential for continued ovulatory ovarian function. 
Although they would not menstruate, they would not be truly menopausal if menopause 
is defined as ovarian failure, rather than simply the absence of menstrual periods. The 
study compared the efficacy of estriol 1 mg, conjugated equine estrogen 1.25 mg, 
estrogen plus progestin, and Remifemin 2 twice daily, but no placebo arm was included. 
All of these women had high menopausal symptom rating using Kupperman‟s index, and 
all treatment groups improved during the 6 month study period. This outcome proves 
only that given time and any sort of treatment modality, women who have multiple 
problems after surgical hysterectomy improve over time. 
Studies in Germany by Schaper Brummer, the manufacturer of Remifemin, and 
by others have demonstrated repeatedly and reassuringly that black cohosh has no 
estrogen activity in vivo. A study that examined endometrial thickness, maturation index 
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of the vaginal epithelium, serum leutinizing hormone, FSH, estradiol, and prolactin 
confirm that black cohosh does not exhibit peripheral estrogenic effects (Liske, 1998). 
Black cohosh does not cause changes in renal, hepatic, or coagulation functions, and has 
no major side effects, except for some minor gastrointestinal complaints. 
The most recent publication on black cohosh was done in 85 breast cancer 
survivors. Subjects received a placebo or black cohosh, 20 mg twice daily. Both the 
treatment and the placebo groups evidenced significant declines in number and intensity 
of hot flashes over time, but the differences between the groups were not statistically 
significant. This study may not be universally applicable. Fifty-nine of the 85 women 
were on tamoxifen. Only nine women who took black cohosh were not taking tamoxifen, 
and these nine women had very marked reductions in symptoms, but the subset was too 
small for independent statistical analysis. These findings do not completely eliminate all 
hopes regarding black cohosh. Tamoxifen may greatly dampen the effectiveness of black 
cohosh (Jacobson, Troxel, and Evans, 2001). Further trials with meticulous study design 
are needed. 
 
 Dong quai. Dong Quai (Angelica sinensis) is also called dang gui and tang kuei 
(Angelica polymorpha Maxim. var Sinesis Oliv, aka A. sinensis [Oliv] Diels). The root is 
used as the female balancing agent in traditional Chinese medicine, and is a panacea for 
almost every gynecologic ailment including hot flashes, dysmenorrhea, oligomenorrhea, 
PMS, amenorrhea, and menopausal syndrome. Dong quai is said to be estrogenic, 
because it has been associated with episodes of uterine bleeding and has uterotropic 
effects in ovariectomized rats. 
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One branded product of dong quai, Rejuvex, also contains bovine ovarian, 
uterine, mammary, and pituitary tissues. The ingestion of bovine brain and spinal cord 
tissue imposes a high risk for development of new variant Creutzfeldt-Jakob disease, also 
known as bovine spongiform encephalopathy or mad cow disease. Considering an 
absence of proved efficacy, adulteration with animal tissues, and potential for 
photosensitization, neoplasia, coagulopathy, and herb-drug interactions, practitioners 
should advise women to avoid dong quai. 
 
 Evening primrose. Evening primrose (evening star, Oenothera biennis L family 
onagraceae) is a source of linolenic acid, a type of omega-3 essential fatty acid. Other 
sources include cold water fish, canola oil, soybean oil, and a few vegetable oils. Gamma 
linolenic acid comes from seed oils of current, borage, and evening primrose. These fatty 
acids are eicosanoid precursors and are part of cell membranes. The pathway for dietary 
gamma linolenic acid leads to dihomo-gamma-linolenic acid, which in turn is converted 
by inflammatory cells to 15-(S)-hydroxy-8, 11, 13-eicosatrienoic acid and prostaglandin 
E1, with potent anti-inflammatory activity. Gamma linolenic acid and dihomo-gamma-
linolenic acid seem to affect inflammatory processes by regulating T lymphocytes, and 
gamma linolenic acid inhibits angiogenesis. Null results were found in the one, well-
constructed clinical trial using evening primrose oil for menopause (Chenoy, Hussain, 
and Tayob, 1994). 
 
 Ginseng. The genus name for many types of ginseng, Panax, derives from the 
word panacea, meaning cure-all. Regarding menopause, Wiklund, Mattsson, Lindgren, 
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and Limoni (1999) reported a relatively large and long-term study of G115, the active 
ingredient in a commercial product sold in the United States and Europe called Ginsana. 
A randomized, multicenter, double-blind, parallel group study was done in 384 
postmenopausal women over a 16 week period. They reported that hot flashes were no 
better in the treatment arms versus the placebo arms. 
 
 Soy- and red clover-based isoflavone supplements. Soy and red clover, Trifolium 
pratense, are legumes and rich sources of a large number of phytoestrogens. Although 
soy is the most common source of isoflavones in the human diet, red clover is the richest 
source of isoflavones of any plant. Red clover is also a rich source of coumestans, a 
phytochemical with steroid-like activity. 
 A number of isoflavone isolates are being promoted in the United States as 
alternatives to isoflavones from soy foods. The source plant material is washed with 
alcohol and the isoflavones, which are alcohol soluble, are extracted. The alcohol is 
evaporated and the remaining isoflavone residue is packaged as a food supplement. 
Literature promoting the use of isoflavone isolates refers to observational studies on 
populations who consume high soy diets, and then suggest that supplements can provide 
similar health benefits. Products such as Healthy Woman from soy and Promensil from 
red clover are being heavily promoted as alternatives to pharmaceutical estrogens here 
and abroad. 
 Trials of various isoflavones isolates for hot flashes have been equivocal. A red 
clover–derived commercial preparation containing 40 mg total isoflavones was given to 
51 women, and 43 women received a placebo. Barber, Templeman, and Morton (1999) 
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found after the 6-month crossover trial that the product was not more effective than a 
placebo. Hot flash frequency decreased in both of the groups, 18% and 20% in the 
treatment group and the placebo group, respectively. Knight, Howes, and Eden (1999) 
studied the same product using isoflavone, 40 mg, 160 mg, or a placebo for 12 weeks. 
Hot flash frequency decreased in all groups by 35%, 29%, and 34%, respectively. 
Isoflavone isolates cost around $22 to $50 per month. The evidence does not support this 
kind of extravagant expenditure.  
 The use of traditional medical treatments including hormones, nonhormonal 
medical drugs, and alternative treatments for hot flashes have been shown to be 
beneficial, yet they also have negative side effects or do not have enough evidence to 
indicate that they are effective. In many cases, such as with HRT, the negative side 
effects can be dangerous and life threatening. More research is needed to find safe and 
effective options for women with hot flashes. Hypnosis may be one of these options. 
 
Hypnosis 
Hypnosis can be defined several ways. One definition is that hypnosis involves the 
induction of a state of mind in which a person‟s normal critical or skeptical nature is 
bypassed, allowing for acceptance of suggestions. This state of heightened receptivity for 
suggestions (induction) is developed with the cooperation of the patient and is followed 
by the delivery of positive suggestions (Elman, 1964; Fromm, 1987). Hypnosis is also 
described as an “attentive, receptive focal concentration,” with the trance state being a 
“normal activity of a normal mind,” which occurs regularly, as when reading an 
absorbing book, watching an engrossing movie, daydreaming, or performing monotonous 
HYPNOSIS AND MENOPAUSE  45 
activity (Spiegel, Greenleaf, & Spiegel, 2000). A common assumption is that, during 
hypnosis, the subconscious mind is in a suggestible state and the conscious mind is 
distracted or guided to become dormant. 
The American Psychological Association‟s (APA) Division of Psychological 
Hypnosis issued a formal definition of hypnosis in 1985. They defined hypnosis as “A 
procedure during which a health professional or researcher suggest that a client, patient, 
or subject experience changes in sensations, perceptions, thoughts, or behavior.” 
In 1999, APA‟s Division of Psychological Hypnosis went a step further in addressing 
hypnosis stating that, “Hypnosis is not a type of therapy like psychoanalysis or behavior 
therapy. Instead, it is a procedure that can be used to facilitate therapy.” 
     In 2003, the APA Division 30 gave a more detailed definition of hypnosis. They stated 
that:  
Hypnosis typically involves an introduction to the procedure during which the 
subject is told that suggestions for imaginative experiences will be presented. The 
hypnotic induction is an extended initial suggestion for using one‟s imagination, 
and may contain further elaborations of the introduction. A hypnotic procedure is 
used to encourage and evaluate responses to suggestions. When using hypnosis, 
one person  (the subject) is guided by another (the hypnotist) to respond to 
suggestions for changes in subjective experience, alterations in perception, 
sensation, emotion, thought or behavior.  
For the purpose of this research, hypnosis was defined as an altered, concentrated 
and focused form of inner attention that then enhances the subject‟s acceptance and use 
of a particular suggestion which is then evidenced in specific emotional, cognitive, 
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behavioral and physiological responses (P. L. Accaria, personal communication, 
February 14, 2007.).  
Within any study about hypnosis, the subject of hypnotic responsiveness, or 
hypnotizability, must be discussed. Hypnotizability refers to individual differences in 
suggestibility as a function of the induction of hypnosis (Weitzenhoffer, 1980).  
Differences in response to hypnosis have been recognized since the time of Mesmer, who 
is considered the “founder” of hypnosis (d‟Elson, 1965). Braid, an English physician 
during the 19th century and originator of the term hypnosis, noted that “there is a 
remarkable difference in the degree if susceptibility of different individuals to the 
hypnotic influence, some becoming rapidly and intensely affected, others slowly and 
feebly so” (1962, p. 72). But it was not until the turn of the century that these long 
observed differences in the individual response to hypnosis eventually led to the 
development of the first viable measures of hypnotizability, the Stanford Hypnotic 
Susceptibility Scale, Forms A and B (SHSS:A and SHSS:B) by Weitzenhoffer and 
Hilgard (1959). The introduction of the Stanford Hypnotic Susceptibility Scale, Form C 
(SHSS:C) by Weitzenhoffer and Hilgard (1962) represented an improved version of the 
two earlier forms; it was composed of a greater proportion of more difficult cognitive 
items. The SHSS:C is still the prevalent measure of hypnotic susceptibility in current use 
and is often the criterion by which other measures of hypnotizability are evaluated (Perry, 
Nadon, & Button, 1992). A recent study by Kurtz & Strube (1996), comparing a number 
of hypnotic measures, described the SHSS:C as the gold standard of susceptibility tests. 
The Stanford Hypnotic Clinical Scale for Adults (SHCS:A) was developed in the late 
1970‟s by Morgan and Hilgard. The SCHS:A is a brief scale designed to measure 
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hypnotic responsiveness, producing a rating of patient hypnotic susceptibility, ranging 
from 0 (low) to 5 (high). The reliability of the SCHS:A was found to have a correlation of 
.72 with the SHSS:C (Morgan & Hilgard, 1978/1979) and has been used in much clinical 
research (Price & Barber, 1987; Kuyk, Spinhoven & van Dyck, 1999; Rucklidge & 
Saunders, 1999; Patterson & Jenson, 2003; Bryant, Moulds, Guthrie & Nixon, 2005). The 
SCHS:A was the scale used in this present research. 
As previously stated, numerous studies have shown the benefits of hypnosis for a 
wide range of medical disorders in contemporary medicine (Stewart, 2005), including 
anesthesia for pain relief and surgery, healing from surgery or injury, dermatology, 
gastroenterology, hematology, neurology, obstetrics, oncology, otorhinolaryngology, 
smoking cessation, rheumatology, and urology.  
 
 Anesthesia for pain relief. Numerous studies have shown the benefits of hypnosis 
for pain relief (Simon, & Lewis, 2000; Lu, Lu, & Kleinman, 2001). A meta-analysis 
published in 2000 evaluated the use of hypnosis for pain relief in the preceding 20 years 
(Montgomery, DuHamel, & Redd, 2000). That review of 18 studies indicated that 
hypnosis offered a moderate to large analgesic effect for many types of pain. It was 
determined that hypnosis met “the criteria for well established treatment”. Hypnosis was 
noted to benefit most patients, and therefore a broader application of its use was 
advocated. A 2003 comprehensive review by Patterson & Jensen observed hypnosis for 
pain relief and found it superior to placebo for acute pain and, at times, superior to pain 
relief achieved by other means. It was concluded that hypnosis for chronic pain was a 
viable option and a useful component of a “multidimensional assessment and treatment.” 
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 Anesthesia for surgery. A report from the 1960s indicated that surgical patients 
should be considered in a state of hypnosis and suggested that patients were able to 
comprehend much of the conversation around them, even while under anesthesia (Cheek, 
1962). In the perioperative state, the patient is fixated on the forthcoming process and is 
in a receptive, compliant state of mind, comparable to the state formally induced with 
hypnosis. The article cautioned that patients in this receptive state may interpret 
comments made within an audible range as having negative implications for them. More 
recently, it has been emphasized again that health care personnel should be aware that 
patients under anesthesia have unconscious auditory perception and tend to interpret 
comments negatively (Erickson, 1994). The report also stressed the fact that, along with 
the potential deleterious effects of this awareness, the opportunity arose for using 
“semantics of positive suggestion” (emphasizing comfort, safety, and success) that should 
be “an integral part” of surgical and obstetrical care. It appears appropriate to consider 
the use of suggestions for patients in the perioperative period as a part of the practice of 
hypnosis. 
Hypnosis has been used as the sole agent of anesthesia for both major and minor 
surgical procedures. The use of hypnosis as the sole agent for anesthesia has been 
virtually abandoned because of the availability and dependability of pharmacological 
agents. Nevertheless, a few such cases have been described in contemporary medical 
literature. An oral surgeon documented his own cholecystectomy (surgery to remove the 
gallbladder) performed with use of only self-hypnosis for anesthesia (Rausch, 1980). He 
walked back to his room after surgery and returned to work on the 10th postoperative 
day. 
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A 1991 review of clinical trials using hypnosis, suggestion, or relaxation in the 
care of surgical patients found that 89% of the trials showed that these techniques 
produced a positive outcome in facilitating physical or psychological recovery from 
surgery (Blankfield, 1991). The use of live therapists (rather than suggestions from 
audiotapes) and positive and appropriate semantics (avoiding words that bring to mind 
undesired outcomes) at the most receptive times were advocated to foster shorter hospital 
stays, to support earlier recovery, and to improve patient well-being.  
A 1999 review by Faymonville, Meurisse, and Fissette, of more than 1650 
surgical cases using hypnosis combined with other methods for conscious sedation 
promoted not only the safety, but also the comfort of the patient afforded by hypnosis. 
Hypnosis was used instead of general anesthesia for a broad range of surgical procedures. 
The authors concluded that hypnosis prevents pharmacological unconsciousness, allows 
patient participation, and may allow a faster recovery and a shorter hospital stay. Other 
studies support the multiple benefits of hypnosis as an adjunct to conscious sedation for 
many types of surgery (Weinstein & Au, 1991; Lang, Joyce, Spiegel, Hamilton, & Lee, 
1996; Faymonville, Mambourg, and Joris 1997; Lang, Benotsch, & Fick, 2000; 
Montgomery, Weltz, Seltz, & Bovbjerg, 2002).  
 
 Healing from surgery or injury. Hypnosis has been evaluated for its effectiveness 
in the use of suggestion to facilitate faster wound healing after injuries or surgery. 
Research by Ginandes & Rosenthal (1999) examined hypnosis for patients with non 
displaced ankle fractures and showed marginally faster healing, diminished pain, and 
increased mobility and functionality. A meta-analysis evaluated hypnosis for surgical 
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patients for its overall effect and benefits for specific clinical outcomes. Hypnosis as an 
adjunct to surgery was believed to be “successful for the majority of individuals”, with 
benefits such as decreased pain, anxiety, nausea, and recovery time (Montgomery, David, 
Winkel, Silverstein & Bovbjerg, 2002). Ginandes, Brooks, Sando, Jones, and Aker, 
(2003) compared the relative efficacy of an adjunctive hypnotic intervention, supportive 
attention, and usual care only on early post-surgical wound healing. Hypnosis was found 
to have the best outcome for wound recovery. 
 
 Dermatology. Many trials have evaluated hypnosis for eliminating warts (Spanos, 
Williams, & Gwynn, 1990; Ewin, 1992; Shenefelt, 2000; Goldstein, 2005, Lankton, 
2007)). Hypnosis was advocated to avoid pain and scarring, reactions to anesthetics, and 
the need for wound care and special equipment. The technique may be particularly 
applicable for warts in sensitive or inaccessible areas. 
Hypnosis has been used successfully for other dermatologic conditions. Patients 
with atopic dermatitis noted decreased pruritus, scratching, sleep disturbance, and tension 
after treatment with hypnosis (Stewart & Thomas, 1995). In many patients, 
improvements persisted at follow-up evaluations up to 18 months later.  
 
 Gastroenterology. Hypnosis for irritable bowel syndrome (IBS) has been studied 
extensively, showing significant benefits from hypnosis (Prior, Colgan & Whorwell 
1990; Houghton, Heyman, & Whorwell, 1996; Galovski & Blanchard, 1998; Vidakovic-
Vukic, 1999; Gonsalkorale, Houghton & Whorwell, 2002). It was concluded that “in 
addition to relieving the symptoms of irritable bowel syndrome, hypnotherapy 
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profoundly improves the patient‟s quality of life and reduces absenteeism from work.” 
(Houghton, Heyman, & Whorwell, 1996). Other studies and reviews have shown similar 
results for IBS (Palsson, Turner, Johnson, Burnett, & Whitehead, 2002; Spanier, 
Howden, & Jones, 2003). Hypnosis was the primary treatment for IBS in a study 
conducted by Galovski, and Blanchard (2002). After 6 hypnotherapy treatments, the IBS 
symptomatology had improved 53%. 
Patients with peptic ulcer disease have benefited from hypnosis. In a study of 126 
patients with functional dyspepsia (a pain or an uncomfortable feeling in the upper 
middle part of the stomach caused by a stomach ulcer or acid reflux disease), those 
treated with hypnosis noted improvement in quality of life and long-term symptoms, 
fewer physician visits, and less health care spending compared with the group treated 
with medication (Calvert, Houghton, Cooper, Morris, & Whorwell, 2002). 
Postoperative gastrointestinal motility has been affected positively by hypnosis. 
Patients scheduled to undergo abdominal surgery were assigned randomly either to a 
treatment group that were read suggestions for an early return of bowel function and 
appetite or to a control group, given only general preoperative instructions for an equal 
period (Disbrow, Bennett, & Owings, 1993). With their surgeons unaware of the study, 
patients who were read a 5-minute script before surgery had a significantly earlier return 
of bowel function (P<.05). They also had a shorter mean duration of hospital stay (6.6 vs. 
8.1 days) and a cost savings of $1200 per patient.  
Hypnosis has been used alone or in combination as anesthesia for liver biopsy, 
esophagogastroduodenoscopy, and colonoscopy. A gastroenterologist reported the use of 
only an anesthetic throat spray and hypnosis for 200 upper gastrointestinal tract 
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endoscopy procedures with a reduced overall duration of the procedure (Zimmerman, 
1998). No complications were noted, and patients were able to leave immediately 
afterward. In another report, patients either with anxiety or with allergy to local 
anesthetics safely underwent liver biopsies with use of hypnosis (Adams & Stenn, 1992). 
80% of patients in a pilot trial using hypnosis before colonoscopic evaluations noted only 
mild or no discomfort (Cadranel, Benhamou & Zylberberg, 1994). 
Hematology 
One medical center reported favorable results with the addition of hypnosis for 
patients with hemophilia (LaBaw, 1992). Patients who were assigned to receive hypnosis 
had a significantly decreased need for transfusions, compared with controls (p =.01).  
 
 Neurology. Hypnosis has been used successfully for treatment of headaches. 
Patients with chronic (>=6 months) tension headaches were assigned, at random, either to 
a group receiving hypnosis or to a control group (Melis, Rooimans, Spierings, & 
Hoogduin, 1991). The hypnosis group had a significant reduction in the number, 
duration, and intensity of headaches. Instruction in self-hypnosis produced significant 
benefits for tension headaches in other studies (Spinhoven, Linssen, Van Dyck & Zitman, 
1992; ter Kuile, Spinhoven, Linssen, Zitman, Van Dyck, & Rooijmans, 1994).  
 
 Obstetrics. Hypnosis as an anesthesia for childbirth has a long, successful history. 
A large trial compared a self-hypnosis group with a control group to study the effects of 
hypnosis on labor (Jenkins & Pritchard, 1993). The hypnosis group reported less 
discomfort and shortened labor. Another study looked at pregnant adolescents who were 
assigned randomly to individual sessions of hypnosis or to supportive counseling. The 
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medical staff was blinded to their group assignments (Martin, Schauble, Rai & Curry Jr., 
2001). At delivery, the hypnosis group had a significant decrease in complications, fewer 
surgical interventions, and a shorter hospital stay.  
 
 Oncology. Chemotherapy often is associated with nausea and vomiting. Hypnosis 
has been studied for reducing these and other adverse effects (Jacknow, Tschann, Link & 
Boyce, 1994; Walco, Conte, Labay, Engel, & Zeltzer, 2005). Zeltzer, Dolgin, LeBaron 
and LeBaron (1991) studied the effects of hypnosis with children and found that children 
receiving chemotherapy who were assigned randomly to hypnosis had less anticipatory 
nausea and vomiting and less vomiting with chemotherapy, compared with a control 
group. There was also a significant decrease in the need for antiemetic (preventing 
vomiting) medications. Children who learned self-hypnosis techniques were believed to 
have gained feelings of control over their situations.  
Hypnosis has been used successfully in other areas of oncology. Patients 
undergoing bone marrow transplantation treated with hypnosis experienced significantly 
less oral pain than control patients (Syrjala, Cummings & Donaldson, 1992). 
A National Institutes of Health panel issued a statement published by the AMA in 
1996 indicating that there was “strong evidence for the use of hypnosis in alleviating pain 
associated with cancer.”  A study conducted by Lynch (1998) investigated how hypnosis 
could be a successful adjunct to the treatment of cancer. Specific areas of usefulness 
include the management of stress and anxiety, the modulation of pain, the diminution of 
treatment- and disease-related anorexia, nausea, and emesis, and achieving with the 
patient some sense that he or she is again somewhat in control of life and disease. 
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 Otorhinolaryngology. In a study by Attias et al. (1993), patients with chronic 
tinnitus treated with hypnosis improved significantly in 7 of 10 disturbing symptoms, 
compared with a group treated with masking techniques or supportive measures (P<.05).  
 
 Smoking cessation. Numerous studies have reported various techniques and 
outcomes in the use of hypnosis for smoking cessation, many with beneficial results. In a 
1992 meta-analysis of 633 smoking-cessation studies involving almost 72,000 
participants, hypnosis was the most successful cessation method, with a 12% to 60% 
success rate (mean, 36%), 3.5 times that achieved by self-care methods (Viswesvaran & 
Schmidt, 1992). More aggressive but less acceptable techniques that combined hypnosis 
with aversion methods (rapid smoking with negative imagery and electrical shocks) for 
smoking cessation resulted in a 3-month abstention rate of 86% in male volunteers and 
87% in female volunteers (Johnson & Karkut, 1994). Another study that combined 
hypnosis with aversion methods reported a 90% abstention rate (39 of 43 consecutive 
referral patients) at 6 to 36 months (Barber, 2001). 
A 2000 review of 59 studies showed a greater than 50% success rate, with 3 
studies (200 participants total) documenting 12-month abstention rates of 63% to 88% 
(Green & Lynn, 2000).  
One study examined the effect of suggestions for smoking cessation delivered 
during elective surgery. In a double-blind trial, 122 patients listened to audiotapes during 
general anesthesia containing either simple or direct suggestions to stop smoking or 
simple counting without suggestions (Hughes, Sanders, Dunne, Tarpey & Vickers, 1994). 
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After 1 month, significantly more patients in the suggestion group (8 patients) had 
stopped smoking compared with no patients in the control group (P<.005). No patient 
could actively recall the message on the tape. This is one of several studies supporting the 
assertion that postoperative behavior can be influenced by suggestions given during 
general anesthesia without conscious recall of the suggestions. 
 
Rheumatology. Patients with refractory fibromyalgia (mean duration, 8.5 years) 
who were randomly assigned to receive hypnosis obtained significant improvement 
compared with those assigned randomly to physical therapy alone (Haanen, Hoenderdos 
& van Romunde, 1991). Benefits included improvements in morning fatigue, in sleep, in 
muscle pain, in overall assessment, and in use of pain medications, with results persisting 
for at least 6 months. 
 
 Urology. Since the 1960‟s,  medical literature has indicated a strong potential for 
the use of hypnosis for impotence (Elman, 1964) and support for this assertion has come 
from recent clinical trials. A review of a study by Crasilneck (1990) cited an 88% success 
rate using hypnosis for impotence in almost 3000 patients. The hypnosis techniques used 
in this trial were studied in 2 randomized controlled trials of men with nonorganic 
impotence. One trial that compared hypnosis with a placebo showed an 80% 
improvement in sexual function with hypnosis compared with 36% with a placebo 
(Aydin, Odabas, Ercan, Kara & Agargun, 1996). The second trial compared hypnosis 
with acupuncture and an injected or an oral placebo. The success rate (moderate 
improvement or “cure”) was 75% for hypnosis (Aydin, Ercan & Caskurlu, 1997).  
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 Menopausal symptoms in cancer patients. Only one study was found that used 
hypnosis to control menopausal symptoms. This was a study that investigated whether or 
not hypnosis would be beneficial for breast cancer survivors in the reduction of hot 
flashes (Elkin, Marcus, Palamara & Stearns, 2004). The treatment for breast cancer often 
puts women into an early menopause. In two case studies hypnosis was found to be 
effective 77% and 76% of the time.  
In the Elkins et al. study, the women were experiencing menopause that was 
medically induced due to the medicine used for the treatment of breast cancer. The 
protocol that was used required the women to imagine themselves in a cool environment 
when they initially felt the hot flashes occurring. This present research will examine the 
use of hypnosis for naturally occurring menopause and the protocol will be more 
proactive than in the Elkins study. The treatment given to the women, instead of being 
useful when a hot flash occurs, will lessen or diminish the frequency and intensity of the 
hot flashes before they occur. 
For the purposes of this qualitative study, research questions were posed rather 
than specific hypotheses stated. The first question explored the experience of women who 
are menopausal and the ways in which this affects their quality of life. Next, this study 
looked at the frequency and intensity of hot flashes for woman in three different areas: 
negative thoughts, negative feelings, and physical discomfort. This study also 
investigated whether or not hypnosis is a viable treatment to control or eliminate hot 
flashes in women who are experiencing naturally occurring menopause. Finally this study 
also looked at whether or not the hypnotic treatment works better for women with a 
higher hypnotic responsiveness.  





A total of 3 participants were involved in the present study. The women were 
experiencing hot flashes occurring from natural menopause. They were private clients 
that were seen in this investigator‟s Toms River, NJ counseling office. 
 
Measures 
The Hot Flash Rating Scale (HFRS) was developed by George McCloskey, Ph.D. 
and the investigator for the purpose of this study (See Appendix A). On the HFRS, the 
women use a 5 point Likert scale to measure the frequency and intensity of their hot 
flashes in 3 different areas: negative thoughts, negative feelings, and physical discomfort. 
The HFRS was administered before the treatment had been given, one week after the 
treatment, and then again 2 weeks later during a follow-up session. The investigator, in 
collaboration with Philip Accaria, Ph.D wrote the treatment scripts that were used during 
this study : the Progressive Muscle Relaxation Induction and Treatment Script (Appendix 
B) and the Treatment for Hot Flashes protocol (Appendix C). The Treatment for Hot 
Flashes protocol is the hypnosis script that was used with the participants.  
The Stanford Hypnotic Clinical Scale for Adults (SHCS:A)(Appendix D) was 
read verbatim to the participants. The SCHS: A is a brief scale designed to measure 
hypnotic responsiveness, producing a rating of patient hypnotic susceptibility ranging 
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from 0 (low) to 5 (high). Their experiences were recorded and scored for responsiveness 
to the exercises.  
 
Procedures 
 Each woman was asked to participate in 3 sessions. The sessions ranged from 60 
to 90 minutes and all but the last were spaced at one week apart. All sessions were 
conducted in the investigator‟s counseling office in Toms River, New Jersey.  
During the first session each subject was asked to fill out The HFRS for the first 
time and was read the Progressive Muscle Relaxation Induction and Treatment Script . 
The subjects were then asked to return after a week for the second session. The second 
session included the participants providing a verbal report about the nature of their hot 
flash symptoms during the previous week. The subjects were then asked to complete the 
HFRS; following its completion, they were asked to come back 2 weeks later for the third 
and final session. 
 During the third session the subject was given the HFRS for the last time. The 
purpose of this was to see how the effects of the treatment held up over time. During this 
session the SHCS: A was also administered to the subjects. One of the objectives of this 
study was to examine whether or not the hypnotic treatment works better for women with 
a higher hypnotic responsiveness.  
 
Data Analysis 
This study examined the effectiveness of hypnosis treatment from a descriptive 
point of view. The responses from the three participants were graphed. Evidence was 
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gathered from the 3 participants using additional sources such as their reactions to the hot 
flashes and how these impacted their lives. The hypnotizability of the women was 
observed and compared with their scores on the HFRS. 




The goal in conducting the present study was to answer several questions: 
1. What is the experience of women who are menopausal and how does this 
affect their quality of life? 
2. What is the frequency and intensity of hot flashes for women in three different 
areas: negative thoughts, negative feelings, and physical discomfort? 
3. Is hypnosis a viable treatment for controlling or eliminating hot flashes in 
women who are experiencing naturally occurring menopause? 




 Subject 1 is a 53 year old woman. She was married for 14 years although she and 
her husband had been together for 22 years. During the course of her participation in the 
present study, she and her husband were divorced and she describes their relationship as 
“still good friends”. She recently began talking with someone on an online dating service 
and was “bummed out” because he did not turn out to be as he described himself to be. 
She was hopeful, however, that she would eventually meet someone.  
Subject 1 describes herself as being “happy about my life”. Other than the hot 
flashes, Subject 1 does not see menopause as a negative experience nor does she see 
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getting older as anything but having “more candles on a cake” and another “reason to 
have a party”.  
Subject 1 has no children. She is employed and added that she “loves her job” and 
feels that she is very good at it. Subject 1 reports that she is “very healthy” but added that 
she is about 40 pounds overweight. She is presently taking Lipitor for cholesterol and 
Celexa for depression. She has been taking Celexa for 8 or 9 years and describes a long 
history of depression dating back to high school. Besides using Black Cohosh, which she 
did not find helpful, she has never used any medical or nonmedical treatment for her hot 
flashes.  
Subject 1 has not had a menstrual period for 4 years. She began having symptoms 
10 to 12 years ago and described them in the following way:  
“At age 41 I started to notice that I became hateful, angry, wimpy, emotional, cried at the 
drop of a hat and I couldn‟t stop. That continued until a year after post menopause so 
probably until 2004 or 2005. It was very long. In another way it was very weird. My 
mom died very young. My sister had a hysterectomy. And my aunt died very young so I 
don‟t know what their experience was. I have a cousin who had a similar experience to 
me. But it was the 10 – 12 year plan. And the only thing that hasn‟t gone away is the hot 
flashes”.  
 She added that what she hated the most is the sweating. Before menopause she 
did not consider herself a “sweater” but during the first session described herself as a “fat, 
hot, sweaty pig” and added that every part of her body sweats, even her earlobes. Subject 
1 complained that she is embarrassed sometimes to go dancing, which used to be a 
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favorite activity, because now she sweats a lot. Her face gets red and the sweat makes her 
hair look thinner and stick to her head.  
She said, “I hate sweating. I hate being hot. I have a fan at both of my desks. I 
have two offices. I have the fan on me at all times. And even when I work at home I have 
the fan on me at all times. I think it is temperature related. But I have the ceiling fan and 
if it is really hot, I put on the air conditioner. Most people would be freezing in my room. 
I just don‟t seem to be able to regulate my temperature. The regulator is broken. I rarely 
get cold and I haven‟t worn a winter coat in years”. 
 
Hypnosis experience. Subject 1 had never been hypnotized before but had wanted 
to try hypnosis for her depression at a previous time in her life because, as she stated: 
“I think, like with the depression, I think I could convince myself to not feel that 
way. And I know it is chemical. My life is wonderful. I have nothing to be 
depressed about. But I still have anxiety. I still have that feeling, that empty hole. 
So I kept thinking that maybe that would work”. When she was asked what her 
thoughts or ideas were about being hypnotized she reported, “I think the thought 
is quite intriguing. I am a firm believer that our brain is much more powerful then 
we use. In fact I had wanted to do it several years ago but the only hypnotic 
person I knew was a pervert skeevy. So I thought I will just wait until another 
opportunity comes”.  
 
During the pretreatment session, Subject 1 filled out the Hot Flash Rating Scale 
(HFRS) for the first time. She was asked to rate the frequency of her flashes in 3 different 
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areas: negative thoughts, negative feelings, and physical discomfort.  She rated the 
frequency of negative thoughts about her hot flashes as a 3. A score of 3 is defined as: I 
have had negative thoughts about my hot flashes on several days but not every day. She 
also rated the frequency of negative feelings about her hot flashes as a 3, which is defined 
as, I have had negative feelings about my hot flashes on several days but not every day. 
She also rated the frequency of physical discomfort about her hot flashes as a 3, which 
corresponds to the statement: I have had physical discomfort related to my hot flashes on 
several days but not every day.  
During the pretreatment session Subject 1 was also asked to rate the intensity of 
her hot flashes in the same 3 areas: negative thoughts, negative feelings, and physical 
discomfort. She rated the intensity of negative thoughts as a 3. A score of 3 is defined as: 
Negative thoughts about my hot flashes are somewhat intense; sometimes they are 
slightly disruptive when they occur. She also rated the intensity of negative feelings about 
her hot flashes as a 3, which is defined as Negative feelings about my hot flashes are 
somewhat intense; sometimes they are slightly disruptive when they occur. She also rated 
the intensity of physical discomfort about her hot flashes as a 3, which corresponds to the 
statement: The physical discomfort related to my hot flashes is somewhat intense; 
sometimes it is slightly disruptive when they occur.  
At the end of the pretreatment session, the Progressive Muscle Relaxation 
Induction and Treatment Script was read to Subject 1 (See Appendices E and F). She was 
asked to return the following week. 
 When Subject 1 returned the following week she was debriefed about how her hot 
flash symptoms had been. She made several comments worth noting:   
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“I am doing really good. This week I had 2 night sweats compared to 5 the week 
before. A couple of times I was able to stop the hot flashes in the day as soon as I 
felt the onset just by thinking the word relax.”   
During the posttreatment session, Subject 1 was again asked to complete the 
HFRS. She rated the frequency of negative thoughts about her hot flashes as a 2. A score 
of 2 corresponds to the statement: I have negative thoughts about my hot flashes on only 
a few days. She also rated the frequency of negative feelings about her hot flashes as a 2. 
A 2 is defined as, I have negative feelings about my hot flashes on only a few days. She 
also rated the frequency of physical discomfort as a 2, which corresponds to the 
statement: I have had physical discomfort related to my hot flashes on only a few days.  
During the posttreatment session Subject 1 was also asked to rate the intensity of 
negative thoughts about her hot flashes for the previous week. She rated the intensity of 
the negative thoughts as a 2. A score of 2 corresponds to the statement, Negative thoughts 
about my hot flashes are mild and do not disrupt what I am doing when they occur. She 
also rated the intensity of negative feelings about her hot flashes as a 2. A 2 is defined as: 
Negative feelings about my hot flashes are mild and do not disrupt what I am doing when 
they occur. She also rated the intensity of physical discomfort as a 2, which corresponds 
to the statement: The physical discomfort related to my hot flashes is mild; it does not 
disrupt what I am doing when it occurs. Subject 1 was then asked to return for a follow 
up session after 2 weeks. 
 Subject 1 returned for her final session after 2 weeks. The following are several 
comments that she made about her symptoms for the previous 2 weeks:  “It has been 
quite delightful. I sweat a little at night. It has actually been quite delicious. I feel 
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wonderful.”  When she was asked to describe her overall experience she added, “I 
thought it was going to be like flipping a switch but it feels more gradual. I‟m still doing 
well. Overall the hot flashes have diminished. It went from 4 to 5 a week to 0 in 2 
weeks”.  
During the 2-week follow-up session, Subject 1 was again asked to fill out the 
HFRS and rate the frequency of her hot flashes in the 3 areas: negative thoughts, negative 
feelings, and physical discomfort. She described the frequency of negative thoughts about 
her hot flashes as a 1. A one corresponds to the statement: I have not had negative 
thoughts about my hot flashes on any day. She also rated her frequency of negative 
feelings about her flashes as a 1, which corresponds to the statement: I have not had any 
negative feelings about my hot flashes on any day. She also rated the frequency of 
physical discomfort about her hot flashes as a 1, which corresponds to the statement: I 
have not had physical discomfort related to my hot flashes on any day.  
During the 2-week follow-up session, Subject 1 was also again asked to fill out 
the HFRS and rate the intensity of her hot flashes. She described the intensity of her 
negative thoughts about her hot flashes as a 1. A 1 corresponds to the statement: There is 
no intensity and no disruption occurs because I have not had any negative thoughts about 
my hot flashes. She also rated the intensity of negative feelings about her flashes as a 1 
which corresponds to the statement: There is no intensity and no disruption occurs 
because I have not had any negative feelings about my hot flashes. She also rated her 
intensity of physical discomfort about her hot flashes as a 1, which corresponds to the 
statement: There is no intensity and no disruption occurs because I have not had any 
physical discomfort related to my hot flashes. 
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Figure 1 presents the scores for Subject 1 on the HFRS. These scores were based 
on the self-report responses of the participant‟s perceptions of her frequency of hot 
flashes at 3 different sessions; pretreatment, posttreatment and then again after the 2-
week follow-up session.  
 
 
 Figure 1. Frequency of hot flashes - Subject 1 
 
Figure 2 presents the scores for Subject 1 on the Hot Flash Rating Scale HFRS 
with regard to the intensity of her hot flashes. These scores were based on the self-report 
responses of the participant‟s perceptions at 3 different sessions: pretreatment, Post  
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Figure 2. Intensity of hot flashes - Subject 1 
 
Subject 2 
 Subject 2 is a 49 year old woman. She has been divorced since 2000 and describes 
her life as being “very stressful”. She has a 22 year old daughter who is away at college. 
She is presently living with her mother who, she reports, “is very depressed and has been 
all my life”. She has been unemployed since 2007 and does not feel hopeful about finding 
a job as a teacher soon. She has recently placed her name on several lists for substitute 
positions. Subject 2 would have liked to be at a “better place at this point in her life” and 
added that she had “hoped to be happily married, happily employed and not always 
worrying about money”.  
Subject 2 appears to be a very bright woman and can speak 5 languages. 
According to Subject 2, she is in “excellent health” and works out on a regular basis. She 
reports that she lost 55 pounds last year by exercising and eating healthy. She stated, “I 
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At first when I started to crave sweets, the willpower kicked in. Exercise has a lot to do 
with it”. 
Subject 2 appeared to be a very anxious person and often seemed to be on the  
verge of crying. She finds it difficult being alone. She has recently started a relationship 
that she feels “hopeful” about but added, “I tend to get very involved much too fast and I 
did it again this time”.  
Subject 2 has not had a menstrual period since July of 2007. The following is how 
she describes her symptoms:  
“I keep waking up drenched, completely drenched. I am seeing someone and it‟s like 
every 5 minutes the covers are off, the covers are on and off. I don‟t give myself and 
anyone else peace and I don‟t give the people around me any peace. My heart starts to 
pound and I can just feel it. It is like the furnace fire is up. They are really noticeable at 
night. I wake up. They are unpredictable. I had them during the day and I can feel them 
starting up and the heat starts to radiate down my body, down my core. They last for 
about a minute. I start to sweat. I can feel my heart pounding. My breathing becomes 
rapid. I used to get very emotional with PMS. I would cry at the drop of a hat. Even now 
I get very emotional. I actually think that stress put me into menopause earlier. I 
completely lost my period for 3 months a few years ago. I read a couple of books and 
they said that stress can affect it. I eventually got my period back on a regular basis. 
Subject 2 added that her hot flashes are embarrassing because her face gets red; 
she sweats a lot and she feels as if she cannot breathe. Her heart starts to pound and she 
feels as if she is going to throw up. She also feels as if she is losing control of herself at 
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those times. She added that this is a major problem for her because she likes to feel as if 
she is in control at all times. 
Subject 2 has tried Estroven, Black Cohosh, and Red Clover for her hot flashes, 
without success. She is presently not using any medical or nonmedical treatment for her 
symptoms.  
 
 Hypnosis experience. Subject 2 has never been hypnotized before. She reports 
that she has considered it before saying, “I actually have come across self hypnosis books 
a couple of times and I thought that would be cool. It has peaked my curiosity about what 
it would be like”.  
During the pretreatment session Subject 2 filled out the Hot Flash Rating Scale 
(HFRS) for the first time. She was asked to rate the frequency of her hot flashes in 3 
different areas: negative thoughts, negative feelings, and physical discomfort. Subject 2 
rated her frequency of negative thoughts about her hot flashes as a 4. A score of 4 is 
defined as: I have had negative thoughts about my hot flashes a few times each day. She 
rated her frequency of negative feelings about her hot flashes as a 4, which is defined as: 
I have had negative feelings about my hot flashes a few times each day. She rated the 
frequency of physical discomfort about her hot flashes as a 5, which corresponds to the 
statement: I have had physical discomfort related to my hot flashes many times each day.  
During the pretreatment session Subject 2 was also asked to rate the intensity of 
her hot flashes in the same 3 areas: negative thoughts, negative feelings, and physical 
discomfort. She rated the intensity of the negative thoughts about her hot flashes as a 5. A 
score of 5 is defined as: Negative thoughts about my hot flashes have been extremely 
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intense; they greatly disrupt whatever I am doing when they occur. She rated the intensity 
of negative feelings about her hot flashes as a 4 which is defined as: Negative feelings 
about my hot flashes are intense; they disrupt to some degree whatever I am doing when 
they are present. She also rated the intensity of physical discomfort about her hot flashes 
as a 4 which corresponds to the statement: The physical discomfort related to my hot 
flashes is intense; it disrupts to some degree whatever I am doing when it occurs.  
At the end of the pretreatment session the Progressive Muscle Relaxation 
Induction and Treatment Script was read to Subject 2 (See Appendices E and F). She was 
asked to return the following week. 
When Subject 2 returned the following week, she was debriefed about how her 
hot flash symptoms had been the previous week. According to Subject 2 she was doing 
well for 3 days and then, “Things fell apart. I was able to feel relaxed and when I felt a 
hot flash start I could just relax. But then my life got so crazy I wasn‟t able to do that. I 
felt very much rejected because of a relationship that I was very hopeful about. I just kept 
thinking about that. My life has become even more stressful and I am not able to stop 
thoughts once they occur.” 
During the posttreatment session, which was a week after the treatment, Subject 2 
again was asked to rate the frequency of her hot flashes in 3 different areas: negative 
thoughts, negative feelings, and physical discomfort. She rated the frequency of negative 
thoughts about her hot flashes as a 2. A score of 2 corresponds to the statement: I have 
negative thoughts about my hot flashes only on a few days.  She also rated the frequency 
of negative feelings about her hot flashes as a 2. A 2 is defined as: I have negative 
feelings about my hot flashes on only a few days. She rated the frequency of physical 
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discomfort as a 4 which corresponds to the statement: I have had physical discomfort 
related to my hot flashes a few times each day.  
During the posttreatment session, Subject 2 rated the intensity of her hot flashes in 
3 different areas: negative thoughts, negative feelings, and physical discomfort. She rated 
the intensity of her negative thoughts about her hot flashes as a 3. A score of 3 
corresponds to the statement: Negative thoughts about my hot flashes are somewhat 
intense; sometimes they are slightly disruptive when they occur. She rated the intensity of 
negative feelings about her hot flashes as a 2. A 2 is defined as: Negative feelings about 
my hot flashes are mild and do not disrupt what I am doing when they are present. She 
rated the intensity of physical discomfort as a 4, which corresponds to the statement: The 
physical discomfort related to my hot flashes is intense; sometimes it disrupts to some 
degree whatever I am doing when it occurs. Subject 2 was asked to return for a follow up 
session after 2 weeks. 
When Subject 2 came back for the final session she was asked about her hot flash 
symptoms during the previous 2 weeks. She reported that, “I just forgot about them. Like 
today I was in the middle of a task, helping someone, and I felt one coming on, and I just 
forgot about it”. When she was asked if she was able to do that before, she responded that 
she was not. According to Subject 2, the hot flashes have decreased in the overall 
frequency. She added, “During the day they have decreased and during the night I only 
remember 2 nights that I woke up. It was happening almost every night but now only 2 
hot flashes. It has decreased them for me”. When she was asked how she would describe 
the overall experience, she replied, “It was good. I would recommend it to someone.”   
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During the 2-week follow-up session, Subject 2 was again asked to fill out the 
HFRS and rate the frequency of her hot flashes in 3 different areas: negative thoughts, 
negative feelings, and physical discomfort. She described the frequency of her negative 
thoughts about her hot flashes as a 2. A 2 corresponds to the statement: I have negative 
thoughts about my hot flashes on only a few days. She also rated the frequency of 
negative feelings about her flashes as a 1 which corresponds to the statement: I have not 
had negative feelings about my hot flashes on any day. She rated the frequency of 
physical discomfort about her hot flashes as a 2, which corresponds to the statement: I 
have had physical discomfort related to my hot flashes on only a few days. 
During the 2-week follow-up session, Subject 2 was also asked to fill out the 
HFRS and rate the intensity of her hot flashes in 3 different areas: negative thoughts, 
negative feelings, and physical discomfort. She described the intensity of her negative 
thoughts about her hot flashes as a 2. A 2 corresponds to the statement: Negative thoughts 
about my hot flashes are mild and do not disrupt what I am doing when they occur. She 
also rated the intensity of negative feelings about her flashes as a 2, which corresponds to 
the statement: Negative feelings about my hot flashes are mild and do not disrupt what I 
am doing when they are present. She rated the intensity of physical discomfort about her 
hot flashes as a 3, which corresponds to the statement: The physical discomfort related to 
my hot flashes is somewhat intense; sometimes it is slightly disruptive when it occurs. 
Figure 3 presents the scores for Subject 2 on the HFRS. These scores were based 
on the self-report responses of the participant‟s perceptions of the frequency of her hot 
flashes at 3 different sessions; pretreatment, posttreatment and the 2-week follow-up 
session.  
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Figure 3. Frequency of hot flashes - Subject 2 
 
Figure 4 presents the scores for Subject 2 on the Hot Flash Rating Scale (HFRS). 
These scores were based on the self-report responses of the participant‟s perceptions of 
her intensity at 3 different sessions; pretreatment, posttreatment and then again after a 2-
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Figure 4. Intensity of hot flashes - Subject 2 
 
Subject 3 
Subject 3 is a 53 year old “happily” married woman. She reported that she doesn‟t 
think menopause is a “big deal” and although some of her friends are dreading getting 
older she could “care less”. In fact, if it weren‟t for the hot flashes, Subject 3 says that she 
“would happily grow old with her hubby”. She has no children and added that she tried 
very hard to have children and used fertility drugs and treatments for many years. She has 
worked in the same career field for 25 years and reports to like her job. According to 
Subject 3, she is in good health and has never taken any medical or nonmedical treatment 
for her hot flash symptoms. She added that she was always afraid to take any more 
hormones or chemicals after her many failed fertility treatment attempts. 
Subject 3 has not had a menstrual period for 6 years. She is very much concerned 
about how long she will continue to have symptoms because her mother is still having 
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“I can‟t imagine having hot flashes for all those years. I wouldn‟t know what to do. My 
symptoms have started out just like my mother‟s. When I first started getting hot flashes 
it was mostly at night but now, for the past 4 or 5 years, it has been at this level.”   
Subject 3 reports that she has hot flashes,  
“During work on tasks, anytime I get in line or a crowd with people, an elevator, 
all day, all night. I can‟t wear stockings and I have to wear short sleeves in winter. 
I feel like I am going to pass out, tired, lack of sleep, anxious, and quick to snap at 
people. I want to get naked and stand in front of a fan. When a hot flash starts I 
often feel dizzy, sweaty, nauseas, overwhelmed. They keep me from sleeping. I 
get tired and crabby. When I feel one starting, I stop breathing. I have to 
remember to breathe. I get them a minimum of 6 a day and 2 times at night. At 
night I wake up wet then get cold all night.” 
 
 Hypnosis experience. Subject 3 has been hypnotized before and found it to be 
very helpful. She reports that she was going through a very stressful time in her life and 
was unable to eat without feeling nauseous. She went to a local psychologist and with 1 
treatment she was able to eat.  
During the pretreatment session, Subject 3 filled out the HFRS for the first time. 
She was asked to rate the frequency of her flashes in 3 different areas: negative thoughts, 
negative feelings, and physical discomfort.  She rated the frequency of negative thoughts 
about her hot flashes as a 5. A score of 5 is defined as: I have had negative thoughts 
about my hot flashes many times each day. She also rated the frequency of negative 
feelings about her hot flashes as a 5, which is defined as: I have had negative feelings 
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about my hot flashes many times each day. She also rated the frequency of physical 
discomfort about her hot flashes as a 5, which corresponds to the statement: I have had 
physical discomfort related to my hot flashes many times each day.  
Subject 3 was also asked to rate her intensity of hot flashes in 3 different areas: 
negative thoughts, negative feelings, and physical discomfort. She rated the intensity of 
negative thoughts about her hot flashes as a 5. A score of 5 is defined as: Negative 
thoughts about my hot flashes have been extremely intense; they greatly disrupt whatever 
I am doing when they occur. She also rated the intensity of negative feelings about her 
hot flashes as a 5, which is defined as: Negative thoughts about my hot flashes have been 
extremely intense; they greatly disrupt whatever I am doing when they are present. She 
also rated the intensity of physical discomfort about her hot flashes as a 5, which 
corresponds to the statement: The physical discomfort related to my hot flashes is very 
intense; it greatly disrupts whatever I am doing when it occurs. At the end of the 
pretreatment session the Progressive Muscle Relaxation Induction and Treatment Script 
was read to Subject 3 (See Appendices E and F). She was asked to return the following 
week. 
When subject 3 returned for the posttreatment session, she was debriefed about 
her hot flashes the previous week. Subject 3 reported that she had seen a “great 
improvement” and had been able to stop many of her hot flashes totally when they first 
began. She added:  
“On several occasions I have been in situations where I could not stop what I was 
doing to use the technique and the flashes took over. I have had a lot of success in 
totally stopping flashes and feel a lot better. I have noticed that I am not taken 
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over by nausea and anxiety as often as I was prior to using the technique. I have 
even seen an improvement when I am driving or in a crowd. I have less anxiety all 
around. The only time that I have no control is when I flash during my sleep. I 
wake up totally wet and have to change pillows and sheets. Overall I am thrilled 
with my ability to have some control of my body again. I can‟t wait to see what 
happens in the coming weeks!” 
During the posttreatment session, which was a week after the treatment, Subject 3 
was asked to rate the frequency of her hot flashes in 3 different areas: negative thoughts, 
negative feelings, and physical discomfort.  She rated the frequency of negative thoughts 
about her hot flashes as a 3. A score of 3 corresponds to the statement: I have had 
negative thoughts about my hot flashes on several days but not every day.  She also rated 
the frequency of negative feelings about her hot flashes as a 3. A 3 is defined as: I have 
had negative feelings about my hot flashes on several days but not every day. She rated 
the frequency of physical discomfort also as a 3, which corresponds to the statement: I 
have had physical discomfort related to my hot flashes on several days but not every day.  
Subject 3 was also asked to rate the intensity of her hot flashes in 3 different 
areas: negative thoughts, negative feelings, and physical discomfort. She rated the 
intensity of negative thoughts about her hot flashes as a 3. A score of 3 corresponds to the 
statement: Negative thoughts about my hot flashes are somewhat intense; sometimes they 
are slightly disruptive when they occur. She also rated the intensity of negative feelings 
about her hot flashes as a 3. A 3 is defined as: Negative feelings about my hot flashes are 
somewhat intense; sometimes they are slightly disruptive when they occur. She rated the 
intensity of physical discomfort also as a 3, which corresponds to the statement: The 
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physical discomfort related to my hot flashes is somewhat intense; sometimes it is slightly 
disruptive when it occurs.  
When Subject 3 returned for her final session, she was again debriefed about her 
hot flash symptoms over the past two weeks. Subject 3 reported the following:  
“Overall I feel better and less negative. Only discomfort is when I wake up from a flash. 
No negative feelings since I have some control back. During sleep I cannot control 
anything. I still wake up wet. I have had a decrease in the number of times my sleep is 
interrupted. I have slept without a fan several days a week. This has helped with hot 
flashes but more importantly it has decreased episodes of anxiety that I frequently 
experience while driving and standing in line. I just breathe. Thank you!  This has been a 
life saver for me.”  
Subject 3 was again asked to fill out the HFRS for the last time. She was asked to 
assess the frequency of her hot flashes in 3 different areas: negative thoughts, negative 
feelings, and physical discomfort. She described the frequency of her negative thoughts 
about her hot flashes as a 1.5. She was not able to decide between 1 and 2. She stated that 
because she still had a few hot flashes at night a 1.5 would better correspond to her 
frequency of negative thoughts about her hot flashes. She rated the frequency of negative 
feelings about her flashes as a 1, which corresponds to the statement I have not had 
negative feelings about my hot flashes on any day. She rated the frequency of physical 
discomfort about her hot flashes as a 1.5. Subject 3 felt that because she still had a few 
hot flashes during her sleep, a 1.5 would best describe her frequency of physical 
discomfort. 
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She was also asked to assess the intensity of her hot flashes in the same 3 areas: 
negative thoughts, negative feelings, and physical discomfort. She described the intensity 
of her negative thoughts about her hot flashes as a 1.5. She was not able to decide 
between 1 and 2. She stated that because she still had a few hot flashes at night a 1.5 
would best describe the intensity of negative thoughts about her hot flashes. She rated the 
intensity of negative feelings about her flashes as a 1, which corresponds to the 
statement: There is no intensity and no disruption occurs because I have not had negative 
feelings about my hot flashes. She rated the intensity of physical discomfort also as a 1 
which corresponds to the statement: There is no intensity and no disruption occurs 
because I have not had physical discomfort related to my hot flashes. 
Figure 5 presents the scores for Subject 3 on the Hot Flash Rating Scale HFRS. 
These scores were based on the self-report responses of the participant‟s perceptions at 3 
different sessions; pretreatment, posttreatment and then again after a 2-week follow-up 
session.  
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Figure 5. Frequency of Hot Flashes - Subject 3 
 
Figure 6 presents the scores for Subject 3 on the Hot Flash Rating Scale HFRS. 
These scores were based on the self-report responses of the participant‟s perceptions at 3 
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Figure 6. Intensity of Hot Flashes - Subject 3 
 
Stanford Hypnotic Clinical Scale for Adults 
The Stanford Hypnotic Clinical Scale for Adults (SHCS: Adults) was given to 
each subject as part of their last session. Each subject was read the SHCS: Adult verbatim 
(see Appendix D) which, after being placed into a comfortable trance, takes the person 
through a series of 5 different exercises to measure her hypnotic responsiveness. These 
exercises include: moving hands together, having a dream, age regression, posthypnotic 
suggestion, and amnesia. One point is given for each of the five exercises. The figure 
below shows that all three subjects scored a three. They were able to move their hands 
together, have a dream, and regress to a younger age. They were not able to produce a 
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In conducting a qualitative study on the use of hypnosis as an effective treatment 
for the hot flashes caused by naturally occurring menopause, and to also explore the 
perception and experiences that women have about menopause, the aim of this study was 
to answer four questions: 1. What is the experience of women who are menopausal and 
how does that affect their quality of life?  2. What is the frequency and intensity of hot 
flashes for women in three different areas: negative thoughts, negative feelings, and 
physical discomfort?  3. Is hypnosis a viable treatment for controlling or eliminating hot 
flashes in women who are experiencing naturally occurring menopause, and 4. Does the 
hypnotic treatment work better for women with a higher hypnotic responsiveness? 
 
Question 1:  Menopausal experience and quality of life. For subject 1, the 
transition into menopause was a slow and long process lasting over ten years. In those ten 
years she experienced many physical and psychological symptoms including moodiness, 
irritability and hot flashes. After several years post-menopause all of her symptoms, 
except for the hot flashes, went away. She describes herself as being “happy about my 
life” and has a job that she loves and one that she feels she does well. Although she is 
recently divorced and “bummed out” by the disappointment of an online dating 
experience, she is optimistic about finding another partner.  
Besides the hot flashes Subject 1 does not see menopause as a negative 
experience nor does she see getting older as anything but having “more candles on a 
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cake” and another “reason to have a party”. This is consistent with Avis & McKinlay 
(1991) and Hunter (1992), who reported that most women report neutral or positive 
attitudes about menopause.  Although she has experienced depression for several 
decades, starting initially in high school, Subject 1 does not think that menopause has 
made her depression worse. This is consistent with findings that suggest that some 
women may experience a slight heightening of psychological distress during 
premenopause (Bromberger & Matthews, 1996) and perimenopause (Hunter, 1990); 
however, there is no notable heightening of psychological distress in menopausal or 
postmenopausal women (Hunter, 1990b; Matthews et al., 1990; Stewart, Boydell, 
Derzko, & Marshall, 1992).  
Subject 1 reported the same embarrassment and a fear of loss and control that was 
consistent with Hunter and Liao (1995), who found that one-third of women with hot 
flashes described embarrassment, and 20% described a general sense of loss of control. 
Subject 2 describes her life as being “very stressful” and added that she would 
have liked to be at a “better place at this point in her life”. She had “hoped to be happily 
married, happily employed and not always worrying about money”. At the present time 
Subject 2 is unemployed, not very optimistic about finding a job as a teacher in the near 
future, and because of financial reasons needed to move into her mother‟s home whom 
she describes as being “very depressed and has been all my life”.  
Psychologically, Subject 2 is a very anxious and depressed person.  She often 
feels like crying and has a difficult time being alone. During the course of her 
participation in this study she and a new relationship broke up and as a result she had 
difficulty sleeping and functioning during the day because of intrusive and ruminating 
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thoughts. She did not feel as if she could “control her thoughts”.  This was a particular 
concern to her because as she described the fact that she “likes to feel as if she is in 
control at all times”.  
Subject 2 is experiencing menopause just as she has experienced other 
developmental and life style changes, with difficulty and stress. This is consistent with 
studies by Costa, et al. (1987), and Matthews, et al. (1990) who found that the frequency 
of prior depression indicates that psychological distress is a stable characteristic over the 
lifetime. If women report psychological distress at menopause, they are likely to have 
previous episodes of distress, such as anxiety or depression. Woods & Mitchell (1996) 
also reported continuity of signs of depression over the life course and that women who 
experienced depressed mood consistently reported more stress and were more likely to 
have a history of premenstrual symptoms (PMS) than women with an absence of 
depression. This is consistent with Subject 2‟s PMS experiences. Also consistent with 
previous research by Hunter and Liao (1995), Subject 2 feels as if she is losing control 
and feels a sense of embarrassment when she is having a hot flash.  
Subject 3 describes the quality of her life in positive ways: happily married and in 
a long standing career that she reports to like. She added that she does not think 
menopause is a “big deal” and although some of her friends are dreading getting older 
she could “care less”. In fact, if it weren‟t for the hot flashes, Subject 3 says that she 
“would happily grow old with my hubby”. As with Subject 1, this is consistent with Avis 
& McKinlay (1991) and Hunter (1992), who reported that most women report neutral or 
positive attitudes about menopause. The only area of menopause that bothers her is the 
hot flashes. For Subject 3, the hot flashes have been a major concern and affect her in 
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many ways including causing her to be irritable, anxious, tired, as well as making her feel 
physically ill.   
It would appear that the 3 women in this study experienced the developmental 
phase of menopause in similar ways as they had experienced other changes in their lives 
and reflected their present quality of life. Subject 1 and Subject 3 appeared to be, overall, 
optimistic and dealing with their lives events in a positive way. Subject 2‟s life is 
different from either of the other two women and she is less optimistic and less hopeful 
about the direction in which her life is going.  
The 3 women in this study appear to be typical of other women reported in 
menopausal research; their hot flash symptoms interfere with many aspects of their lives 
and cause a feeling of loss of control. As those who have been in previous menopausal 
research discovered, these women did not believe that any depression that they may have 
had before menopause worsened as they went through menopause. After the hypnosis 
treatment all 3 women felt as if they had gained control back in their lives; they felt a 
sense of efficacy over their hot flashes and also felt generally less stressful.  
 
Question 2 and Question 3: Frequency and intensity of hot flashes and hypnosis as a 
viable treatment. 
 For all 3 subjects the frequency and intensity of the hot flashes interfered with 
many aspects of their lives. The responses to the HFRS indicated that the hot flashes 
impacted their feelings, thoughts, and physical discomfort on a daily basis. After the 
treatment, all 3 women reported a decrease in their symptoms. After the treatment, 
Subject 1 reported “It has been quite delightful. I sweat a little at night. It has actually 
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been quite delicious. I feel wonderful.”  When she was asked to describe her overall 
experience she added, “I thought it was going to be like flipping a switch but it feels more 
gradual. I‟m still doing well. Overall the hot flashes have diminished. It went from 4 to 5 
a week to 0 in 2 weeks”. For Subject 2 the hot flashes also decreased. She reported, “It 
was good. I would recommend it to someone.”  Subject 3 also had good results. She 
reported, “This has been a life saver for me.”  She reported that her feeling of well being 
and confidence had generalized to other areas of her life such as work and social 
interactions. 
The hot flashes decreased further after the 2-week follow-up session. This may be 
as a result of the women gaining a sense of control and a feeling of efficacy over their 
bodies and their symptoms, as Subject 3 reported, “Overall I am thrilled with my ability 
to have some control of my body again. I have less anxiety all around. This has helped 
with hot flashes but more importantly it has decreased episodes of anxiety that I 
frequently experience while driving and standing in line.”  
 
Question 4: Hypnotic Responsiveness 
The last question that this study examined is: Does the hypnotic treatment work 
better for women with a higher hypnotic responsiveness?  Hypnotic responsiveness is the 
ability to go into an altered state comfortably and to do so in the presence of another 
person. In order to answer this question, it would be helpful to discuss how hypnotic 
suggestion is experienced in the population in general.  
Hypnotic suggestion can be looked at as a trait that follows a normal distribution 
curve, with the top 10 to 15% being virtuosos and the bottom percentage in vegetative 
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states, so that 65 to70% of people can be hypnotized to a degree that gives them effective 
results (P. L. Accaria, personal communication, January 03, 2009). It is expected that 
most women will benefit from hypnosis because research has shown that most people are 
at least within the mid-range of hypnotizability (Fromm & Nash, 1992).  
The three subjects in this study were able to do three of the five exercises. This is 
consistent with the previously stated research that found even people with an average or 
mid-range level of hypnotizability would benefit from hypnosis.  
 
Contribution to the Field 
Review of the literature had highlighted the lack of research on hot flash 
symptoms from naturally occurring menopause. Although research is available on the 
efficacy of hypnosis and hot flashes for breast cancer survivors (1), the vast majority of 
women are healthy and do not have many alternative treatments that are safe and 
nonintrusive. The recent concerns about hormone replacement therapy (HRT) have made 
women and their doctors unsure about whether or not HRT is safe to use and yet there are 
few alternatives, leaving women who are suffering with hot flashes uncomfortable and 
confused. Hot flashes are not only uncomfortable and disrupt women‟s lives in many 
ways, but they also cause embarrassment and a sense of loss of control.  This study 
demonstrates the fact that hypnosis can be an effective treatment that not only reduces or 
eliminates hot flashes but also gives the women a sense of control back in their lives.  
The need for an effective alternative to HRT is clear. As previously discussed, 
menopause is a significant health issue because it will affect every woman in her lifetime 
and with an unprecedented number of women reaching midlife, and living beyond age 65 
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there needs to be a safe and effective treatment for these women. The use of hypnosis for 
hot flashes from naturally occurring menopause gives psychologists and other mental 
health care providers an excellent opportunity to make a significant impact on their 
female client‟s health and well being.  
 
Limitations of the Study 
 There are several limitations to this study. The most prominent limitation to this 
study is the small sample size. The sample size did not provide the amount of information 
needed in order to utilize statistical measures. This limits the usefulness of the pre/post 
results. The small sample size also affects the external validity of the study and the ability 
to generalize the findings to a larger population.  
Because the subjects were self selected, rather than any randomized means of 
selection, the internal validity of this study was diminished. The women may or may not 
have been typical of the general population. They were open to alternate medicine and 
curious about hypnosis. These 3 women were also highly motivated to decrease or 
eliminate their hot flashes because of the severity and intensity of their hot flashes. 
Research quality is heavily dependent on the individual skills of the researcher; 
therefore, rigor is more difficult to maintain, assess, and demonstrate.  
 The women also had a difficult time fitting their responses into the artificial 
parameters of the likert scale; therefore, the likert scale may not have been the best 
instrument to use. Subject 1 and 2 had difficulty deciding between several scores and 
really struggled to have their experiences fit into the artificial rating scores. Subject 3 did 
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not feel that the parameters accurately assessed her experience so she made up her own 
scores.  
Another limitation of this study was that the protocols used were standardized and 
therefore were read to the subject instead of being individualized. In hypnosis it is always 
more effective for the induction and the suggestion to match the behavior and the 
experience of the subject. This concept is what Erickson considered the “utilization 
principle” (Erickson & Rossi, 1979) and is recognized as being central to Erickson‟s 
work. Erickson often matched the subject‟s ongoing experience and behavior in order to 
facilitate acceptance and change. In a clinical or therapeutic setting, Subject 2 could have 
retreated after her rejection from a relationship and her feelings that “things fell apart” 
after 3 days posttreatment. This „individuation‟ may have yielded more robust results but 
even in the face of this complication and her significant depression and anxiety, she was 
able to gain benefits from this treatment.  
 
Future Research 
 This study was the first attempt to investigate whether or not hypnosis would be 
an effective treatment for the hot flashes from naturally occurring menopause. In future 
research, ideomotor signaling, the use of physical manifestation of conscious and 
unconscious phenomena, might be a more realistic way to ascertain a base line and 
subsequent responses.  Ideomotor questioning provides a convenient means of accessing 
and utilizing sensory, emotional, cognitive and physiological learning without needing to 
navigate through perceptual limitations. Cheek (1994) suggests ideomotor questioning is 
a way to communicate at a physiological level, bypassing cognition altogether. 
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Access to the body-mind gestalt that ideomotor questioning and signaling seems to 
provide, offers much encouragement for ascertaining and providing a more meaningful 
and useful baseline and subsequent measurement of posttreatment result. 
 
Conclusion 
The first research question for this study, “What is the experience of women who 
are menopausal and how does that affect their quality of life?” was answered. The 
interviews and anecdotal information suggested that the women in this study shared 
similar experiences and perceptions that previous research had found, including a sense 
of loss of control and that these 3 women experienced menopause in the same way as 
they had experienced other developmental and life changes. 
The second and third research questions for this study, “What is the frequency and 
intensity of hot flashes for women in three different areas: negative thoughts, negative 
feelings, and physical discomfort?” and “Is hypnosis a viable treatment for controlling or 
eliminating hot flashes in women who are experiencing naturally occurring menopause?” 
were also answered. The results of this study suggested that for all 3 subjects, the 
frequency and intensity of the hot flashes interfered with many aspects of their lives. 
After the treatment, all 3 woman reported a decrease in their symptoms and reported that 
it was a good experience for them, stating, “I feel wonderful”, “It has been quite 
delightful”, “It was good”, “I would recommend it to someone “, “great improvement”, 
and “this has been a life saver for me.”  Subject 3 also commented that overall she feels 
better and less negative. All three subjects felt that they had some control back in their 
lives.  
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The last question “Does the hypnotic treatment work better for women with a 
higher hypnotic responsiveness?” was also answered. The results of this research were 
consistent with the literature and indicated that even people with an average or mid-range 
level of hypnotizability would benefit from this treatment.  
Given the success of past and present studies utilizing hypnosis for medical 
issues, the current study suggests that the use of hypnosis for hot flashes with naturally 
occurring menopause is a promising treatment and warrants further research.   
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Appendix A 
 
Hot Flash Rating Scale 
 
Scale C 
Please rate the frequency of negative thoughts about your hot flashes during the past 
week using the scale below: 
 
1 2 3 4 5 
I have not had 
negative 
thoughts about 
my hot flashes 
on any day. 
I have negative 
thoughts about 
my hot flashes 
only on a few 
days. 
I have had 
negative 
thoughts about 
my hot flashes 
on several days 
but not every 
day. 
I have had 
negative 
thoughts about 
my hot flashes 
a few times 
each day. 
I have had 
negative 
thoughts about 





Please rate the frequency of negative feelings (i.e., being in a bad mood) about your hot 
flashes during the past week using the scale below: 
 
1 2 3 4 5 
I have not had I have negative I have had I have had I have had 
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negative 
feelings about 
my hot flashes 
on any day. 
feelings about 
my hot flashes 




my hot flashes 
on several days 




my hot flashes 









Please rate the frequency of physical discomfort caused by your hot flashes during the 
past week using the scale below: 
 
1 2 3 4 5 
I have not had 
physical 
discomfort 
related to my 
hot flashes on 
any day. 
I have had 
physical 
discomfort 
related to my 
hot flashes only 
on a few days. 
I have had 
physical 
discomfort 
related to my 
hot flashes on 
several days but 
not every day. 
I have had 
physical 
discomfort 
related to my 
hot flashes a 
few times each 
day. 
I have had 
physical 
discomfort 
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Intensity of Hot flashes 
 
Scale C 
Please rate the intensity of negative thoughts about your hot flashes during the past week 
using the scale below: 
 
1 2 3 4 5 
There is no 
intensity and no 
disruption 




my hot flashes. 
Negative 
thoughts about 
my hot flashes 
are mild and do 
not disrupt 














my hot flashes 
are intense; 
they disrupt to 
some degree 















Please rate the intensity of negative feelings (i.e., being in a bad mood) about your hot 
flashes during the past week using the scale below: 
 
1 2 3 4 5 
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There is no 
intensity and no 
disruption 




my hot flashes. 
Negative 
feelings about 
my hot flashes 
are mild and do 
not disrupt 












they are present. 
Negative 
feelings about 
my hot flashes 
are intense; 
they disrupt to 
some degree 
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Scale P 
Please rate the intensity of physical discomfort caused by your hot flashes during the past 
week using the scale below: 
 
1 2 3 4 5 
There is no 
intensity and no 
disruption 








related to my 
hot flashes is 
mild; it does 
not disrupt 
what I am 




related to my 
hot flashes is 
somewhat 
intense; 






related to my 




whatever I am 




related to my 
hot flashes is 
very intense; it 
greatly disrupts 
whatever I am 
doing when it 
occurs. 
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Appendix B 
 
Progressive Muscle Relaxation Induction and Treatment Script 
 
The first thing that I want you to do is to find a spot or mark on the wall or ceiling. I want 
you to look at that spot without blinking your eyes. For as long as you can… look at that 
spot without blinking your eyes. You may notice, that after awhile, the spot will start to 
change in shape.  You may notice that your eyes will become watery or might even 
become dry. I don‟t know which will happen, but you will notice a change. Your eyes 
will also become tired and you will feel the need to close them. When you are ready to do 
that you may go ahead and close your eyes. Notice how good it feels to have your eyes 
closed. How relaxed they have become. Take 5 seconds to feel that relaxation in your 
eyes. Now allow that relaxation to go UP to the top of your head and notice a body of 
water in your minds‟ eye. I don‟t know whether that water will be a lake or a pool or even 
a puddle. Notice how calm the top of the water is. And if a ripple of water appears on the 
surface watch how it slowly becomes calm and the top of the water becomes still. Now, 
allow that relaxation to go DOWN to the face, DOWN to the cheeks, DOWN to the jaw, 
and allow that relaxation to relax the jaw. Now, allow that relaxation to go DOWN into 
the chin, and Down into the neck, and DOWN to the shoulders. Allow that relaxation to 
go DOWN into the arms and DOWN into the wrists and DOWN into the hands and 
DOWN into the fingers. Allow the relaxation to go DOWN into the chest. Notice a 
change in the heartbeat. It may either become faster or you may notice that it slows down. 
Allow that relaxation to go BACK into the lungs and with every breath allow the 
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relaxation to go into every cell of the body. Take a deep breath and allow that relaxation 
to go into every cell of the body. Allow the relaxation to go DOWN into the stomach and 
BACK into the back and DOWN into the hips and DOWN into the thighs. Allow the 
relaxation to go DOWN into the knees and DOWN into the calves and DOWN into the 
ankles and DOWN into the feet. Allow that relaxation to go DOWN into the toes and 
DOWN into the bottom of the feet. With another relaxing breath allow any tension or 
stress to leave the body. Take 5 seconds and scan the body. If there is any tension or 
stress allow that tension or stress to leave the body with another relaxing breath. Notice 
how good it feels to be this relaxed and know that you can become this relaxed at 
anytime you want. All you have to do is think the word RELAX and with a relaxing 
breath allow the body to become RELAXED. Think the word RELAX and with a 
relaxing breath allow the body to become RELAXED. Think the word RELAX and with 
a relaxing breath allow the body to become RELAXED.  
(Insert Treatment for Hot Flashes protocol here) 
In a few moments I will count to five and when I reach five you can continue to enjoy 
feeling and being fully RELAXED, fully awake and able to continue with your normal 
activities. And remember that at anytime you want to feel this quality of relaxation again, 
which then helps your body to produce the perfect amount of hormones and chemicals, 
all you have to do is think the word RELAX and with a relaxing breath allow the body to 
become RELAXED. And so before you reorientate and awaken fully, isn‟t it nice to 
know that you can know what an effective and useful trance this has been, when you 
begin to know that what seemed to take a short time, turns out to have been a long time, 
or what seemed a long time was really no time at all.. 
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One, two, you are become aware of your body and notice the chair that you are sitting on. 
Three. Your eyes are beginning to open, yet still relaxed. Four, your eyes are opened and 
your senses are coming back to you, become more and more alert. Five, fully alert, 
comfortably relaxed and able to continue your daily activities. 
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Appendix C 
 
Treatment for Hot Flashes  
 
After Progressive Muscle Relaxation Induction, but before reawakening. 
 
Know that you can become this relaxed at any time you want by remembering this 
experience and also know that the body can produce the perfect amount of hormones and 
other chemicals needed to subdue any hot flashes as soon as one might occur and because 
you have a conscious and unconscious mind those 2 minds can work independently to 
even further quell and eliminate, if you like, the hot flashes. And isn‟t it interesting and 
curious to know that both minds can do this independently of you. The body can produce 
the perfect amount of hormones and chemicals needed to eliminate any hot flashes before 
they arise or quell and stop them if one had already begun. You can become this relaxed 
and produce the perfect balance of hormones and chemicals to quickly stop hot flashes 
that might begin. The body can regulate its temperature and eliminate any hot flashes 
before they arise or shortly thereafter. 
 
Proceed with reawakening.  
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Appendix D 
 
Stanford Hypnotic Clinical Scale for Adults (SHCS: ADULT) 
 




In a moment I shall suggest to you a number of experiences which you may or may not 
have and a number of effects which you may or may not produce. Not everyone can have 
the same experiences or produce the same effects when hypnotized. People vary greatly.   




Please close your eyes and listen carefully to what I say. As we go on, you will find 
yourself becoming more and more relaxed…Begin to let your whole body relax…Let all 
the muscles go limp…Now you will be able to feel special muscle groups relaxing even 
more. If you pay attention to your right foot, you can feel the muscles in it relax…feel the 
muscles in the right lower leg relaxing…in the right upper leg relaxing…Now on the left 
side concentrate on the way that the left foot is relaxing…and the left leg, how the lower 
part and the upper part are both relaxing more…Next, you‟ll be able to feel the muscles 
of the right hand relaxing, the right lower arm and the right upper arm relaxing…Now 
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direct your attention to your left hand. Let it relax, let the lower arm and the upper arm 
relax…As you have become relaxed, you body begins to feel rather heavy. Just think of 
the chair as being strong, sink into it, and let it hold you…Your shoulders…neck   and 
head, more and more relaxed…The muscles of your scalp and forehead, just let them 
relax even more…All of this time you have been settling deeper and more comfortably 
into the chair. 
    Your mind has relaxed, too, along with your body. It is possible to set all worries aside. 
Your mind is calm and peaceful. You are getting more and more comfortable…You will 
continue to feel pleasantly relaxed as you continue to listen to my voice…Just keep your 
thoughts on what I am saying…more and more deeply relaxed and perhaps drowsy but at 
no time will you have any trouble hearing me. You will continue in this state of great 
relaxation until I suggest that it is time for you to become more alert…Soon I will begin 
to count from 1 to 20. As I count, you will feel yourself going down further and further 
into this deeply relaxed hypnotic state. You will be able to do all sorts of things that I 
suggest, things that will be interesting and acceptable to you. You will be able to do them 
without breaking the pattern of complete relaxation that is gradually coming over you…1 
– you are becoming more deeply relaxed…2 – down, down into a deeper, tranquil state of 
mind…3 – 4 – more and more relaxed…5 – 6 – 7 – you are sinking deeper and deeper. 
Nothing will disturb you. You are finding it easy just to listen to things that I say…8 – 9 
– 10 – halfway there…always deeply relaxed…11 – 12 – 13 – 14 – 15 – although deeply 
relaxed you can hear my clearly. You will always hear me distinctly no matter how 
hypnotized you are…16 – 17 – 18 – deeply relaxed. 
Nothing will disturb you…19 – 20 – completely relaxed. 
HYPNOSIS AND MENOPAUSE  127 
    You can change your position any time you wish. Just be sure you remain comfortable 
and relaxed. 
    You are very relaxed and pleasantly hypnotized. While you remain comfortably 
listening to my words, I am going to help you learn more about how thinking about 
something affects what you do. Just experience whatever you can. Pay close attention to 
what I tell you, and think about the things I suggest. Then let happen whatever you find is 
happening, even if it surprises you a little. Just let it happen by itself. 
1. Moving hands together (or, if one arm is immobile, go to 1a. Hand lowering)  All right, 
then…please hold both hands straight out in front of you, palms facing inward, hands 
about a foot apart. Here, I‟ll help you. (Take hold of hands and position them about a foot 
apart.)  Now I want you to imagine a force attracting your hands toward each other, 
pulling them together. Do it any way that seems best to you – think of rubber bands 
stretched from wrist to wrist, pulling them together – the closer they get the stronger the 
pull…As you think of this force pulling your hands together, they will move together, 
slowly at first, but they will move closer together, closer and closer together as though a 
force is acting on them…moving…moving…closer, closer… 
(Allow ten seconds without further suggestion, and note extent of motion.)   
That‟s fine. Everything is back to normal now. Just place your hands in their resting 
position and relax. 
(Score + if hands move slowly toward each other, and are not more than six inches apart 
at end of ten seconds.) 
1a. Hand lowering (alternative to Moving hands together) 
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If one hand is immobile for any reason, we recommend substituting a hand lowering 
suggestion, similar to that given as Item I in SHSS-C. The arm is held straight out at 
shoulder height, with the palm of the hand up. The suggestion is given to imaging 
something heavy in the hand pressing it down. After a few suggestions of downward 
movement, if the arm is not completely down, a 10-secong wait is introduced. The item is 
passed if the one hand has lowered at least six inches by the end of the 10 seconds. 
2. Dream 
     Now I am going to ask you to keep on relaxing, and this time you are going to have a 
dream… a real dream…much like the kind you have when you sleep at night. When I 
stop talking to you very shortly, you will begin to dream. Any kind of dream may 
come…Now it is as though you are falling asleep, deeper and deeper asleep. You can 
sleep and dream about anything you want to. As soon as I stop talking, you will begin to 
dream. When I speak to you again in a minute or so you will stop dreaming if you are still 
dreaming, and you will listen to me just as you have been doing. If you stop dreaming 
before I speak to you again, you will remain pleasantly and deeply hypnotized. Now just 
sleep and have a dream. 
 (Allow 1 minute. Then say:) 
The dream is over, but you can remember it very well and clearly, very clearly…I want 
you now to tell me about your dream while remaining deeply hypnotized. Please tell me 
about your dream…right from the beginning. Tell me all about it (Record verbatim.) 
 (If subject has no dream:) That‟s all right. Not everyone dreams. 
 (If subject hesitates, or reports vaguely: probe for details.) 
 Inquiry: How real would you say your dream was? 
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 Termination: That‟s all for the dream. Remain as deeply hypnotized as you have 
been. 
(Score + if subject has an experience comparable to a dream…not just vague fleeing 
experiences or just feelings or thoughts. The dream should show imagery, some reality, 
and to give evidence of being under voluntary control.) 
3. Age regression 
Something very interesting is about to happen. In a little while you are going back to a 
happy day in elementary school. If you had a choice to return to the third, fourth, or fifth 
grade, would you prefer one of these to the other? 
 (If yes:)  Which grade? 
 (If no preference, use fourth grade.) 
All right then, I would like you now to think about when you were in the  (selected) grade 
of school, and in a little while, you are going to start to feel like you are growing younger 
and smaller, going back to the time you were in the (selected) grade…1, you are going 
back into the past. It is no longer (state present year), nor (state an earlier year), nor (state 
a still earlier year), but much earlier…2, you are becoming much younger and 
smaller…in a moment you will be back in the (selected) grade, on a very nice day. 3, 
getting younger and younger, smaller and smaller all the time. Soon you will be back in 
the (selected) grade, and you will feel an experience exactly as you did once before on a 
nice day when you were in school. 4, very soon you will be there…Once again a little girl 
in the (selected) grade. Soon you will be right back there. 5! You are now a small girl in 
school…Where are you?...What are you doing?...Who is your teacher?...How old are 
you?...What are you wearing?...Who is with you?... 
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 (Ask additional questions as appropriate. Record answers.) 
That‟s fine…Now you can grow up again. You are no longer in the (selected)grade but 
getting older, growing up. You are now your correct age, this is (current day and date), 
and you are in (locale of testing). You are no longer a little girl, but an adult, sitting in a 
chair deeply hypnotized. How old are you?...And what is today?...Where are you?...Fine, 
Today is (correct date) and you are (correct age) and this is (name place where subject is 
being tested). Everything is back as it was. Just continue to be comfortably relaxed… 
 (Postpone scoring until inquiry at end.) 
4. Posthypnotic suggestion (Clearing throat or Cough) 
5. Amnesia 
Stay completely relaxed, but listen carefully to what I tell you  next. In a little while I 
shall begin counting backwards from ten to one. You will gradually come out of hypnosis 
but you will be the way you are now for most of the count. When I reach “five” you will 
open your eyes, but you will not be fully awake. When I get to “one” you will be entirely 
roused, as awake as you usually are. You will have been so relaxed, however, that you 
will have trouble recalling the things I have said to you and the things you did. It will 
take so much effort to think of these that you will prefer not to try. It will be much easier 
just to forget everything until I tell you that you can remember. You will forget all that 
has happened until I say to you:  “Now you can remember everything!”  You will not 
remember anything until then. After you wake up you will feel refreshed. I shall now 
count backwards from ten, and at “five,” not sooner, you will open your eyes, but not be 
fully aroused until I reach “one.”  At “one” you will be fully awake. A little later I shall 
tap my pencil on the table like this (demonstrate with two taps). When I do, you will feel 
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a sudden urge to clear your throat or to cough. And then you will clear your throat or 
cough. You will find yourself doing this but you will forget that I told you to do so, just 
as you will forget the other things, until I tell you, “Now you can remember everything.”  
All right, ready – 10 – 9 – 8 – 7 – 6 – 5 – 4 – 3 – 2 – 1. 
 (If subject has eyes open:)  How do you feel?  Do you feel alert? 
 (If groggy:)  The feeling will go away soon. You feel alert now! 
 (If subject keeps eyes closed:)  Please open your eyes. How do you feel? 
(If groggy:)  You are beginning to feel more alert and refreshed…You feel alert now! 
(Hypnotist now taps pencil against table twice. Wait ten seconds.) 
(Score + if patient clears throat or coughs after pencil tap.) 
Now I want to ask you a few questions about your experience. Please tell me in your own 
words everything that has happened since I asked you to close your eyes. 
 (Record subject‟s responses verbatim. If blocked ask, “Anything else?” and 
record answers until subject reaches a further impasse.) 
Listen carefully to my words.  Now you can remember everything. Anything else now? 
 (Again record subject‟s responses verbatim. Remind subject of any items not 
recovered; note these also.) 
 (Score + if subject recalls no more than two items before memory is restored.) 
(If subject is awake and comfortable: That‟s all now. You are completely out of hypnosis, 
feeling alert and refreshed. Any tendency that you may have to clear your throat or to 
cough is now completely gone. 
 
FOR CORRECTING DIFICULTIES WHEN NECESSARY: 
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 (If there is residual difficulty, e.g., difficulty in restoring alertness or persistence 
of a cough, proceed as follows with appropriate suggestions:)  Please close your eyes and 
drift back into hypnosis as I count to 5. 1 – 2- 3 -4 -5… Now I am about to arouse you by 
counting backwards from 5 to 1. You will feel alert, refreshed, with no tendency to 
cough. (Wait ten seconds.)  5 -4 -3 0-2 -1. Fully aroused! 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
